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Various mitochondrial inner membrane proteins contribute to the structure of cristae 
membranes and to the overall dynamic morphology of the inner membrane. These 
proteins include the F1FOATPase dimers, which contribute to the curvature and angular 
shape of cristae. Also, Fcj1/Mitofilin are involved in cristae junction formation and act 
in an antagonistic manner in inner membrane curvature with respect to F1FOATPase 
dimers. Whereas several small proteins mediate F1FOATPase dimerization in yeast by 
binding sequentially at monomer interfaces, the exact nature of what promotes 
F1FOATPase dimerization in higher eukaryotes is yet to be determined. To this end, the 
initial aim of this study was to identify novel F1FOATPase dimerization factors in 
higher eukaryotes that parallel the action of small dimerization factors in yeast. An in 
silico approach to identify novel F1FOATPase dimerization factors resulted in the 
identification of the human mitochondrial protein MINOS1 as a potential candidate. 
MINOS1, along with its human homolog, Mio10, were investigated. These proteins 
however were found not to be stably associated with the F1FOATPase. Moreover, 
Mio10 did not affect F1FOATPase dimerization, oligomerization, or enzymatic activity. 
Thus a role of Mio10 and MINOS in dimerization was excluded. Instead by using an 
affinity purification based mass spectrometric analysis, Mio10/MINOS1 were 
identified as novel interaction partners of Fcj1/Mitofilin. Topological analysis of 
Mio10 and MINOS together with results of size exclusion chromatography indicated 
that the two proteins form large mitochondrial inner membrane complexes. 
Furthermore, analysis of a MIO10 deletion strain by fluorescence and electron 
microscopy provided evidence for the critical role that Mio10 plays in inner membrane 
organization. Mitochondria from mio10∆ and fcj1∆ strains exhibited leaflet-like 
stacked cristae membranes and appeared to have lost defined cristae tips. The complex 
that contains Mio10/Fcj1 in yeast and MINOS1/Mitofilin in human mitochondria was 
hence termed as the MINOS complex (Mitochondrial Inner membrane Organizing 
System). The presented findings highlight the functional and evolutionary significance 
of the MINOS complex as a player in mitochondrial inner membrane architecture as 
well as a multifunctional component in eukaryotic mitochondria and potentially in 
other cellular organelles. 
                                                                                                             INTRODUCTION                           
 2 
 
2. INTRODUCTION  
 
Ancient. Versatile. Dynamic. Mitochondria are eukaryotic organelles of α-
proteobacterial origins, possessing their own genome as well as having a protein 
translational machinery (Gray et al., 1999; Fontanesi et al., 2006; Mick et al., 2011). 
The mitochondrial proteome is of dual genomic origin: a mosaic of mitochondrial and 
nuclear encoded proteins. Besides their accustomed role in ATP synthesis by oxidative 
phosphorylation, mitochondria are also involved in cellular metabolism of amino 
acids, lipids and iron-sulfur clusters as well as playing a role in aging and disease 
exemplified by their central roles in apoptosis and production of reactive oxygen 
species (Scorrano et al., 2002; Pan, 2011).  
 
  Mitochondria are highly compartmentalized, due to their enclosure by two 
specialized membranes: the outer and inner membrane. The inner membrane, which 
surrounds the mitochondrial matrix, can be characterized by two distinguishable 
regions: the inner boundary membrane (IBM), consisting of membrane stretches 
adjacent to the outer membrane, and cristae membranes, which are tubular structured 
invaginations of the inner membrane that extend into the mitochondrial matrix (Zick et 
al., 2009). Cristae membranes increase the inner membrane surface-to-volume ratio 
(Frey and Mannella, 2000). They also promote the formation of a diffusion barrier 
between the intermembrane space (IMS) and the intracristal space, leading to various 
bioenergetic consequences, such as the regulation of oxidative phosphorylation by 
limiting diffusion of metabolites like protons and ADP (Mannella et al., 2001). 
Furthermore, it appears that inner membrane complexes localize differentially: with 
the respiratory chain and mitochondrial translational machinery residing in the cristae 
membranes, and the protein import machinery primarily localized at the IBM (Vogel et 
al., 2006). In addition, electron micrographs also revealed that cristae membranes are 
attached to the IBM by narrow openings termed cristae junctions, which appear to be 
constant in size and shape in various organisms (Frey and Mannella, 2000).  
 
Mitochondrial morphology is dynamic and characterized by variable shapes 
and sizes of often interconnected networks; these networks can vary from simple 
tubular networks to more branched elaborate networks (Visser et al., 1995; Egner et 
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al., 2002; Okamoto and Shaw, 2005).  The nature of the mitochondrial network is 
dependent on opposing processes of mitochondrial fusion and fission (Okamoto and 
Shaw, 2005; Hoppins et al., 2007). Moreover, some outer membrane proteins, such as 
Mmm1, Mdm10, and Mdm12 influence mitochondrial morphology (Okomoto and 
Shaw, 2005). However it appears that inner membrane proteins, such as the F1FO ATP 
synthase  (F1FOATPase), OPA1, and Mitofilin play a more critical role in determining 
inner membrane architecture and the biogenesis of cristae membranes. The following 
section reviews the determinants of mitochondrial morphology from its dual-genomic 
respiratory chain complexes to inner membrane proteins that regulate cristae 
biogenesis and architecture.  
 
2.1 Dual genomic mitochondrial proteome 
Phylogenetic analysis and reconstructions based on mitochondrial-encoded proteins 
such as subunits of the cytochrome c oxidase, have illustrated that contemporary 
mitochondria have originated from an ancestral endiosymbiot of α-proteobacterial 
origin (Sicheritz-Ponten et al., 1998; Gray et al., 1999; Gray, 2011). Acquisition of the 
bacterium by early eukaryotic cells is hypothesized to have occurred approximately 
two billion years ago, a time point in which an environmental global event led to a 
dramatic increase in atmospheric oxygen levels (Holland, 1994). The symbiotic 
relationship between the eukaryote and the bacterium, which has potential for aerobic 
respiration signified by the presence of various respiratory chain subunits, provided the 
metabolic advantage leading to mitochondrial selection and subsequent evolution 
(Anderson et al., 2002; Dolezal et al., 2006; Szklarczyk and Huynen, 2010). Evolution 
of mitochondria itself is not only incremental, having occurred over millions of years, 
but also dependent on differential symbiotic relationships and environmental 
conditions, as illustrated by a wide array of mitochondrial genome sizes of different 
organisms (Gray et al., 1999; Gray, 2011). Moreover, the modern mitochondrial 
proteome is a result of a series of processes. These processes consist of the loss of 
ancestral mitochondrial genes, the transfer and integration of mitochondrial genes to 
the nucleus, and also the evolution of nuclear encoded sequences, which are then 
imported to the mitochondria and contribute to the majority of its proteome (Anderson 
et al., 2002). About 99% of the mitochondrial proteome consists of nuclear encoded 
proteins; with the remaining 1% being products of the mitochondrial genome 
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(Chacinska et al., 2009). The yeast mitochondrial genome encodes mainly large multi-
transmembrane hydrophobic subunits of the respiratory chain such as Cox1 of the 
cytochrome c oxidase (Fontanesi et al., 2006). 
 
Nuclear encoded proteins, which are synthesized on cytosolic ribosomes, are 
imported by the mitochondrial import machinery, consisting of the necessary 
complexes, TOM, SAM, TIM23, TIM22, and MIA (Neupert and Herrmann, 2007; 
Chacinska et al., 2009; van der Laan et al., 2010).  Translocases of the outer and inner 
membranes, TOM and TIM respectively, have no bacterial orthologs, having evolved 
from the host nuclear genes during endosymbiosis (Kalrberg et al., 2000; Dolezal et 
al., 2006). Most of the components of the transport machinery formed de novo from 
nuclear encoded genes with some minor exceptions (Anderson et al., 2002; Dolezal et 
al., 2006). The outer membrane protein Sam50 is related to the bacterial outer 
membrane protein BamA (Omp85), whereas homologs of TIM proteins (Tim23 and 
Tim44) can be found in α-proteobacteria (Karlberg et al., 2000; Paschen et al., 2003). 
Furthermore, Tom7, Tom22, and Tom40 of the TOM complex are suggested to have 
an endosymbiotic origin (Maćasev et al., 2004). 
 
2.2 Protein import and biogenesis  
Protein import into mitochondria is dependent on a mitochondrial targeting signal and 
the mitochondrial import machinery, which ensures the correct localization of the 
protein within the highly compartmentalized mitochondria. Proteins can be targeted to 
the mitochondria by containing either an N-terminal cleavable presequence, or 
alternatively by internal signals which span various segments of the protein sequence 
(Pfanner and Geissler, 2001; Neupert and Herrmann, 2007).  Import into various 
mitochondrial compartments is dependent on the intrinsic characteristics of the protein: 
being either a precursor with presequence, a multi-spanning membrane hydrophobic 
precursor, or a β-barrel precursor (Neupert and Herrmann, 2007; van der Laan et al., 
2010). Import contains mainly two components: a sorting/insertion mechanism and a 
receptor, the TOM complex, which is a common component in all import pathways 
(Figure 1). The protein translocating channel of the TOM complex, a β-barrel 
translocase, is composed of Tom40 (Ahting et al., 2001; Becker et al., 2005). Tom22 
acts as the receptor for presequence containing precursors whereas Tom70 acts as a 
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receptor for hydrophobic precursors (Muto et al., 2001; Wu and Sha, 2006). However, 
various proteins have been shown to be dependent on both Tom22 and Tom70 (van der 
Laan et al., 2010). In most cases, precursor proteins interact with Tom20 and Tom5 
after binding to the receptor: this allows the interaction with Tom40 and the 
consequent translocation to the inner membrane (Chacinska et al., 2009). In the case of 
β-barrel precursor proteins, after binding to the TOM complex, the proteins are passed 
to the SAM complex, which then mediates the proper insertion into the mitochondrial 
outer membrane (Wiedemann et al., 2003). Similarly, hydrophobic precursors are 
passed to the TIM22 complex in the mitochondrial inner membrane, which then allows 
the proper insertion and maturation of the protein (Rehling et al., 2003; Peixoto et al., 
2007). In both cases, SAM and TIM22 mediated import; precursors interact with small 
TIM chaperones, composed of Tim9 and Tim10 (Curran et al., 2002). 
 
Alternatively, precursors with presequences interact with the TIM23 complex 
in the mitochondrial inner membrane. The TIM23 complex exists in two distinct forms 
in equilibrium, the TIM23CORE and the TIM23SORT: The TIM23CORE complex mediates 
the translocation of precursor proteins to the matrix whereas the TIM23SORT mediates 
lateral sorting of inner membrane targeted precursor proteins that contain a strop-
transfer signal adjacent to their N-terminal presequence (van der Laan et al., 2010). 
The TIM23CORE works in concert with the PAM complex, which is composed of 
various J-proteins (PAMs) and the mtHsp70 ATPase; the PAM complex utilizes ATP 
hydrolysis to translocate precursor proteins to the matrix (Liu et al., 2003). In parallel, 
the TIM23SORT complex in association with the respiratory chain, laterally releases 
membrane-spanning proteins to the inner membrane (Glick et al., 1992; Chacinska et 
al., 2009). Both TIM23 complexes are dependent on the presence of a membrane 
potential across the inner membrane (Chacinska et al., 2009; van der Laan et al., 
2010). In the absence of a membrane potential, import of precursor proteins is halted at 
the TOM complex (Frazier et al., 2003). Finally, the mitochondrial presequence 
protease (MPP), cleaves the N-terminal presequence after proper translocation or 
lateral release by the Tim23 complex (Yang et al., 1988).  
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Figure 1. Overview of various mitochondrial import pathways. The TOM complex is the 




Additionally, many IMS proteins generally lack N-terminal signals and are 
sorted to the IMS. Their import rather depends on internal cysteine motifs and the 
mitochondrial disulfide pathway, MIA pathway; this pathway has been found essential 
for various IMS proteins (Herrmann and Riemer, 2012). The cysteine motifs interact 
with the Mia40 receptor complex in the IMS (Milenkovic et al., 2007; Sideris and 
Tokatlidis, 2007). Mia40 is an oxidoreductase, which contains a redox-active cysteine 
pair residues directly involved in the oxidative folding of proteins (Banci et al., 2009). 
Furthermore, Mia40 is maintained in its oxidative state by the sulfihydryl oxidase, 
Erv1, which in turn is reoxidized by cytochrome c (Farrell et al., 2005; Bihlmaier et 
al., 2007). Oxidative protein folding by disulfide bond formation is thought to drive 
translocation and targeting to the mitochondrial IMS (Banci et al., 2009). 
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2.3 Oxidative phosphorylation  
Mitochondria are referred to as the powerhouse of the cell due to their central role in 
oxidative phosphorylation. This process, which is mediated by the respiratory chain, 
involves the coupled oxidation of NADH and FADH2 by electron transport and 
subsequent ATP synthesis by the F1FOATPase in the inner membrane (Figure 2). The 
respiratory chain is composed of five large multisubunit protein complexes: NADH 
dehydrogenase (complex I), succinate dehydrogenase (complex II), cytochrome c 
reductase/ cytochrome bc1 complex (complex III), cytochrome c oxidase (complex 
IV), and the F1FOATPase (complex V). In brief, oxidative phosphorylation follows 
electron transport within the respiratory chain, which causes H+ translocation from the 
matrix to the IMS by complexes I, III and IV (Boyer, 1997). This forms a proton 
gradient across the inner membrane. The F1FOATPase then uses the proton motive 
force (the sum of the chemical gradient of H+ ions and the membrane potential) to 
produce ATP from ADP and inorganic phosphate (Boyer, 1997). One should note that 
the yeast Saccharomyces cerevisiae (S.cerevisiae), unlike most eukaryotes, does not 
contain a membrane embedded complex I, but rather NADH dehydrogenases 
associated with the inner membrane (Luttik et al., 1998).  
 
 
Figure 2.  Overview of mitochondrial respiratory chain and oxidative phosphorylation.   
 
2.4 Respiratory Supercomplex Formation  
The molecular organization of the respiratory chain within the mitochondrial inner 
membrane has been addressed by two models: 1) the “liquid-state” model which 
postulates that respiratory chain complexes are arranged randomly and thus diffuse 
latterly and freely in the membrane and 2) the “solid-state” model which postulates 
that respiratory chain complexes associate in an ordered manner to form larger 
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complexes, or supercomplexes  (Vonck and Schäfer, 2009). Evidence for the latter 
model has been firstly shown in bacteria and then in mitochondria from yeast and 
higher eukaryotes (Stroh et al., 2004; Stuart, 2008). In S.cerevisiae, four large 
supercomplexes have been observed by BN-PAGE after solubilization of mitochondria 
in the mild nonionic detergent, digitonin (Figure 3). These complexes are comprised of 
a dimeric F1FOATPase (V2), a dimeric complex III (III2), and a dimeric complex III 
associated with one or two moieties of complex IV (III2IV and III2IV2) (Stuart, 2008).  
 
 
Figure 3.  Structural organization of respiratory chain supercomplexes in yeast. Large 
supercomplexes have been observed by BN-PAGE: a dimeric F1FOATPase (V2), a dimeric 
complex III (III2), and a dimeric complex III associated with one or two moieties of complex 
IV (III2IV and III2IV2). 
 
In contrast, the organization of respiratory chain complexes appeared to be 
distinct in mammals. Supercomplexes in mammals may include complex I as well as 
varying copies of complex IV. Using Blue native PAGE (BN-PAGE) after digitonin 
solubilization, five supercomplex species were observed: a dimeric F1FOATPase (V2), 
a dimeric complex III with a monomeric complex I (III2I1), and a dimeric complex III, 
with a monomeric complex I, associated with 1-3 complex IV monomers: III2I1IV1, 
III2I1IV2, or III2I1IV3 (Schägger and Pfieffer, 2000; Althoff et al., 2011). Moreover, 
under different solubilization conditions such as with TritonX-100, a supercomplex 
containing dimeric complex III, a single complex I, and four copies of complex IV 
(III2I1IV4) were observed (Vonck and Schäfer, 2009). Supercomplexes containing at 
least a single complex I, complex III, and a dimeric IV have been referred to as 
“respirasomes”, which are structural units that can autonomously carry out respiration 
(Schägger and Pfieffer, 2000). Furthermore, supercomplexes have been observed in 
various other species, albeit different configurations, such as plants, which contain 
three major complexes: V2, III2I1 and III2I2 (Eubel et al., 2003).  
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2.5 F1FOATPase: from structure to function  
The multisubunit F1FOATPase is ubiquitous to all living organisms and has been found 
in mitochondrial, bacterial plasma membranes and thylakoid membranes in 
chloroplasts (Walker et al., 1991; Collinson et al., 1994; Boyer, 1997; Seelert and 
Dencher, 2011). The yeast mitochondrial F1FO-ATPsynthase is composed of at least 17 
subunits to form a soluble globular catalytic part, the F1, and a membrane embedded 
part, the FO (Arnold et al., 1998). In addition, various proteins such as Stf1p, Stf2p, 
and Inh1p (IF1 in humans) associate with the F1FOATPase for various 
regulatory/inhibitory functions (Walker, 1994; Arnold et al., 1998; Hong and 
Pederson, 2002). Figure 4 summarizes the subunit composition and nomenclature in 
Escherichia coli (E. coli), the yeast S. cerevisiae, and Homo sapiens (H.sapiens). The 
FO termed “O” due to sensitivity to the inhibitor oligomycin (Racker, 1963). The 
enzyme is a multimeric complex of dual genomic origin, with yeast subunits Atp6, 
Atp8, and Atp9 encoded on the mitochondrial genome and the remaining components 
being nuclear encoded (Walker et al., 1991, 1995; Arnold et al., 1998). A combination 
of structural and biochemical data has shone light on the shape of the complex and its 
enzymatic mechanism (Seelert and Dencher, 2011).  The F1FOATPase has been 
described as a rotary motor, in which proton translocation within the FO portion drives 
the intramolecular rotation of hydrophobic rotor subunits (subunit c oligomers) and 
eventually movement of a central stalk with the catalytic F1 head; this is in concert 
with nucleotide binding, form the basic of ATP synthesis (Stock et al., 1999). 
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Figure 4. Nomenclature and organization of F1FOATPase subunits in yeast and 
H.sapiens. (adapted from Kucharczyk et al., 2009) 
 
2.6 High ordered organization of the F1FOATPase: from dimers to 
oligomers  
Early electron micrographs revealed that the F1FOATPases are found adjacent to one 
another (Burton, 1979). Consequently, deep-etch freeze electron microscopy of 
mitochondria of Paramecium multimicronucleatum, revealed an arrangement of 
F1FOATPase into double rows of particles (Allen et al., 1989). These initial 
observations, followed by biochemical isolations with mild detergents and results 
based on cryo-electrotomographies indicated that the F1FOATPase forms ribbons 
composed of homodimers at the mitochondrial cristae membranes (Schägger and 
Pfieffer, 2000; Strauss et al., 2008; Davies et al, 2011). The F1FOATPase in its dimeric 
form, has been shown in a wide range of organisms such as mammals, plant species, 
Drosophila, and various yeast such as P. anserina, N. crassa, and Y. lipolytica (Straus 
et al., 2008; Davies et al., 2011). Also, higher oligomeric states of the F1FOATPase 
homodimers have been found (Eubel et al., 2003; Krause et al., 2005; Thomas et al., 
2008; De los Rios Castillo et al., 2011). Moreover, studies using atomic force 
microscopy revealed the F1FOATPase dimers in their native environment (Buzhynskyy 
et al., 2007). Even though there is significant evidence of the dimeric form, there is yet 
to be a consensus on the structural nature of homodimeric interactions. Single particle 
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cryoelectron microscopy studies indicate that contact sites between the two monomers 
are located between the two FO membrane portions, whereas other studies revealed an 
involvement of the F1 regions (Seelert and Dencher, 2011).  Furthermore, the angles 
between the two monomers appears to vary dependent on the organism in question:  
the angle varied between 45° and 70° in yeast and Polytomella, while it was found to 
40° for bovine dimers (Seelert et al., 2009).   
 
2.7 Functional roles of the F1FOATPase dimers 
In combining clear native PAGE (CN-PAGE) together with an in-gel activity 
F1FOATPase assay, it was shown that monomers, dimers, or oligomers of the 
F1FOATPase have no significant differences in ATP hydrolysis thus ruling out a role of 
oligomerization in activity (Krause et al., 2005). This led to the proposal of other 
functions with respect to F1FOATPase localization at cristae membranes. First, the 
“quinary structure” model proposes that organizing metabolic enzymes into 
stoichiometric complexes increases the efficiency of substrate channeling (the direct 
transfer of metabolic intermediates to subsequent processing steps) (Srere, 1999). Thus 
together with the associations of other respiratory chain supercomplexes, a 
“respirasome” is formed, which allow easier electron transport between complexes. 
Second, a series of F1FOATPase dimers allows the formation of a strong local 
curvature and thus a local proton trap at the cristae apex (Strauss et al., 2008). The 
stringent ribbon arrangement at the cristae membrane tips generates a local proton 
gradient in the adjacent cristae space, thus optimizing the ∆pH required for the proton 
motive force used for ATP synthesis (Buzhynskyy et al., 2007; Strauss et al., 2008; 
Davies et al., 2011). Moreover, oligomerization of the F1FOATPase in mammals has 
been considered to serve a regulatory role to reduce ATP synthesis in conditions of 
low electron transfer activity and reduced membrane potential (Bornhövd et al., 2006). 
In these instances, oligomerization is thought to be a first-order regulation step, which 
allows the inhibitor protein IF1 to consequentially bind and reduce F1FOATPase 
catalytic activity (Wittig and Schägger, 2009).  
 
From a structural point of view, dimerization stabilizes the holo-enzyme 
structure by connecting the two-stator parts in the dimer (Wittig and Schägger, 2009). 
Oligomerization compensates torques generated on the stators (FO) allowing only rotor 
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(F1) movement, thus blocking energy dissipation, which may result from holo-enzyme 
rotation around its own axis in the absence of an adjacent monomer or holo-enzyme 
(Buzhynskyy et al., 2007).   
 
2.8 F1FOATPase dimerization factors 
In S.cerevisiae, various proteins have been described and characterized to be 
dimerization factors of the F1FOATPase. The current model of F1FOATPase 
dimerization (Figure 5) entails a step-wise assembly in which dimerization factors 
associate to the membrane bound FO (Wagner et al., 2010). Assembly is mediated by 
sequential binding of the various subunits to form the final dimeric form. Assembly 
begins with the association of subunit i (Atp18), followed by subunits g (Atp20) and e 
(Atp21) association to form a primed monomer. Two primed monomers associate to 
give rise to a primed dimer (not shown). Final association of the dimerization factor k 
(Atp19) gives rise to the mature F1FOATPase dimer.  
 
 
Figure 5. Stepwise assembly of the F1FOATPase dimer. Sequential association of subunit g 
(Atp20) and subunit e (Atp21) leads to the formation of a primer monomer. Association of 
subunit i (Atp18) facilitates the incorporation of Atp20 and Atp21. The association of two 
primed monomers forms a mature dimer which stably associates with Atp19.  Figure adapted 
from Wagner et al. (2010). * indicates primed monomer. 
 
The described dimerization factors are not essential for F1FOATPase activity, 
exemplified by unaffected growth of deletion mutants on non-fermentable media 
(Arnold et al., 1998; Paumard et al., 2002a; Soubannier et al., 2002). 
Characteristically, these dimerization factors are of small molecular size and contain a 
single transmembrane domain, which allows them to exert their interaction with the 
membrane embedded FO domain (Arnold et al., 1997, 1998; Soubannier et al., 2002; 
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Paumard et al., 2002a; Wagner et al., 2009, 2010). Atp21 contains a C-terminal coiled-
coil domain, which has been demonstrated to stabilize the F1FOATPase dimeric form 
(Everard-Gigot et al., 2005). Moreover, Atp20 and Atp21 both contain a GxxxG motif 
in their transmembrane domains (Arselin et al., 2003; Bustos and Velours; 2005; 
Saddar and Stuart, 2005; Bornhövd et al., 2006). This motif is characterized by two 
glycine residues separated by any three amino acids, and has been previously been 
demonstrated to stabilize homo- and heterodimers of other membrane proteins such as 
Glycophorin A, by supporting helix-helix interactions of neighboring membrane 
proteins (Russ and Engelman, 2000). To this end, a combination of crosslinking 
approaches and site directed mutagenesis studies has demonstrated the role of the 
F1FOATPase dimerizations motif; any amino acids changes in the GxxxG motifs of 
either Atp20 or Atp21 has abolished dimerization (Arselin et al., 2003).   
 
Besides the small F1FOATPase dimerization factors described above, the IF1 
protein, which inhibits ATP hydrolysis and thus F1FOATPase activity has been 
accredited with a role in promoting dimerization in mammalian mitochondria, but not 
in yeast (García et al., 2006; Campanella et al., 2009; Wittig et al., 2010). Moreover, 
other subunits of the F1FOATPase, such as subunit a, b, h, and γ, have been shown to 
play a role in dimerization (Soubannier et al., 2002; Fronzes et al., 2003). Subunit a, 
component of the ATPase proton channel, localizes to the monomer-monomer 
interface, and has been demonstrated to have an additive effect to subunits Atp20 and 
Atp21 in dimerization (Steed and Fillingame, 2008; Wittig et al., 2008; Wittig et al., 
2010). The peripheral stalk, connecting the F1 and FO domains, is composed of 
subunits b (subunit 4 in yeast) and h. Subunit b and h of two F1FOATPase monomers 
have been shown to be in close proximity to each in the dimer and in proximity to 
subunits Atp18, Atp19, Atp20 and Atp21 (Spannagel et al., 1998; Soubannier et al., 
2002; Velours and Arselin, 2000; Wittig et al., 2008). Indeed, manipulation of subunit 
b first membrane segment and intermembrane space loops prevented dimerization of 
the F1FOATPase (Soubannier et al., 2002). On the other hand, the N and C termini of 
subunit γ, part of the catalytic rotor, have been found to be required for proper 
monomer assembly and dimerization (Dian et al., 2008). 
 
Whereas dimerization factors have been exclusively characterized in 
S.cerevisiae, information is still lacking on what mediates dimerization of the 
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F1FOATPase in higher eukaryotes. Atp20 has a significant homolog (subunit g) in 
mammals and has been described to be part of the holo-enzyme complex, however any 
role in relation to F1FOATPase dimerization has not been described.  
 
2.9 F1FOATPase dimerization and maintenance of cristae morphology  
F1FOATPase dimers and oligomers, which align across cristae membrane tips, are 
directly involved in the maintenance and biogenesis of cristae membranes (Giraurd et 
al., 2002; Paumard et al., 2002b; Gavin et al., 2004; Rak et al., 2007; Velours et al., 
2009). F1FOATPase dimers are conceived to have a role in cristae membrane 
morphology by inducing a strong local positive curvature of the inner membrane in the 
direction of the matrix (Dudkina et al., 2006). This, by part, is due the characteristic 
angle between monomers which has the potential to form an inflexible arc and thereby 
protrusions of the inner membrane (Paumard et al., 2002b).  
 
Whereas dimerization does not affect ATP synthesis and overall respiratory 
capacity of mitochondria, the absence of F1FOATPase dimers is directly linked to 
aberrant mitochondrial inner membrane morphologies (Paumard et al., 2002b; Arselin 
et al., 2003, 2004; De los Rios Castillo et al., 2004; Minauro-Sanmiguel et al., 2005). 
The presence of assembled dimers rather than F1FOATPase activity is required for 
cristae biogenesis (Rak et al., 2007). The absence of the small dimerization factors, 
Atp20 or Atp21, leads to a disorganized inner mitochondrial membrane, which lack 
apparent cristae (Figure 6) (Paumard et al., 2002b; Arselin et al., 2003; Arselin et al., 
2004). Absence of Atp20 or Atp21 subunits causes enlargement of CJ diameters, 
promotes cristae branching as well as a decrease in the number of cristae tips (Rabl et 
al., 2009). Wildtype mitochondria contain poorly defined narrow and diminutive 
cristae, whereas ATP20 and ATP21 deletion mutants have well defined inner 
membrane sheets, composed of two or three concentric double leaflet membrane layers 
which transverse the mitochondria (Paumard et al., 2002b; Arselin et al., 2004). In 
these mutants, the inner membrane is thus described to have ‘onion-like’ structures, 
which are understood to be a result of uncontrolled biogenesis of the inner membrane 
(Arselin et al., 2004).  




Figure 6. Aberrant mitochondrial morphology in ATP20 and ATP21 deletion mutants. 
Figure adapted from Paumard et al., 2002. Electron micrographs; Scale bars indicate 0.5 mm. 
Red arrows indicate abnormal mitochondria. (A) Wildtype; (B) atp18∆; (C) and (D) atp20∆; 
(E) and (F) atp21∆. 
 
In addition, crosslinking F1FOATPase dimers via the b subunits, Atp18, or γ 
subunits has been shown to eliminate cristae (Spannagel et al., 1998; Paumard et al., 
2002b; Gavin et al., 2004). The absence of subunit b (subunit 4/Atp4), involved in 
dimerization, also causes, albeit smaller, onion-like structures (Soubannier et al., 
2002).  Similar small onion-like structures are also observed in rho- mitochondria 
(Paumard et al., 2002b). Since atp4∆ mutants, which lack a fully assembled 
F1FOATPase and rho- mitochondria are respiratory deficient, smaller onion-like 
structures are believed to be formed due to the lack of sufficient energy for the 
biogenesis and extension of the inner membrane observed in ATP20 and ATP21 
deletion mutants (Paumard et al., 2002b). Nonetheless, the presence of a functional 
F1FOATPase is required for cristae biogenesis, exemplified by analysis of Atp1, Atp2, 
and Atp12 mutants, which completely lack cristae (Paumard et al., 2002b).  It is thus 
deduced that the lack of Atp20 or Atp21 in combination with an assembled functional 
F1FOATPase leads to the ‘onion-like’ phenotype observed in the mutants (Paumard et 
al., 2002b; Velours et al., 2009).   
 
2.10 The inner membrane and cristae membrane architecture  
Besides components of F1FOATPase, various other inner membrane proteins play a 
role in inner membrane and cristae organization. These proteins include Mitofilin (and 
its yeast homolog Fcj1) and CHCHD3 (John et al., 2005; Rabl et al., 2009; Darshi et 
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al., 2011). Moreover, certain proteins involved in apoptosis (OPA1/Mgm1) and 
mitochondrial fusion and fission play a part in determining proper cristae morphology.  
 
The highly abundant mitochondrial protein Mitofilin is expressed as two splice 
variants with protein products sized 88 and 90 kDa respectively (Odgren et al., 1996; 
Gieffers et al., 1997). Mitofilin is characterized by a cleavable N-terminal targeting 
sequence, a membrane-anchoring domain, and central coiled coil domain (Odgren et 
al., 1996; John et al., 2005). It is anchored to the inner membrane in which the 
majority of its surface is exposed to the IMS and is enriched in the narrow interface 
located between the inner and outer membranes (Gieffers et al., 1997; John et al., 
2005). A role for Mitofilin in cristae biogenesis has been deduced when its protein 
levels were down-regulated by RNA interference (RNAi) in HeLa cultured cells, in 
which the mitochondrial inner membrane was disorganized into a membranous 
labyrinth composed of tightly packed stacks of membrane sheets (John et al., 2005).  
Moreover, the inner membranes, which had an increased inner membrane to outer 
membrane ratio, were devoid of cristae and cristae junctions, highlighting a role for 
Mitofilin in cristae junction formation (John et al., 2005).   
 
The role of Mitofilin in inner membrane biogenesis appears to be conserved in 
other species. Mutation of the two C.elegans homologs, IMMT-1 and IMMT-2, also 
leads to stacked inner membrane networks and to a reduced number of cristae 
junctions (Mun et al., 2010). Interestingly, the Mitofilin C. elegans homologs, IMMT-
1 and IMMT-2 are described to behave as large complexes associated with the 
F1FOATPase in CN-PAGE (Mun et al., 2010). The yeast homolog, Fcj1 (formation of 
cristae junction 1) is also involved in cristae biogenesis (Rabl et al., 2009). Fcj1, like 
Mitofilin, is enriched at cristae junctions at the mitochondrial inner membrane and is 
primarily exposed to the IMS. Similarly, yeast mutants that lack Fcj1, are devoid of 
cristae junctions and exhibit aberrant mitochondrial morphology exemplified by 
parallel concentric stacks of inner membrane. A direct role for Fcj1 in cristae 
biogenesis has been shown by overexpression of FCJ1, which leads to an increase in 
cristae junction diameters, as well as increased cristae junction formation and 
branching (Rabl et al., 2009). 
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 In addition, there is an antagonism between Fcj1 and F1FOATPase subunits 
Atp20 and Atp21 in controlling local inner membrane curvature and cristae formation. 
Fcj1 does not affect F1FOATPase monomers or dimers but rather impairs the formation 
of higher oligomers (Rabl et al., 2009). Whereas deletion of FCJ1 does not affect 
steady state protein levels of Atp20 or Atp21, nor does the deletion of ATP20 or 
ATP21 affect Fcj1 levels, a double deletion of either FCJ1/ATP20 or FCJ1/ATP21 
leads to the formation of concentric (vesicle-like) cristae membranes completely 
devoid of cristae junctions.  In this antagonistic model, the presence of F1FOATPase 
oligomers and thus dimerization factors Atp20 and Atp21 favors positive membrane 
curvature and ensuing formation of cristae tips (Rabl et al., 2009). In contrast, Fcj1 
destabilizes F1FOATPase oligomerization, thus allowing cristae junction formation by 
favoring negative membrane curvature over positive curvature.  Thus, differential 
localization of Fcj1 and Atp20/Atp21 at the mitochondrial inner membrane allows 
proper cristae junction and cristae tip formations (Rabl et al., 2009).   
 
Immunoprecipitations and a yeast two-hybrid assay indicated that Mitofilin 
form a homotypic interaction assembling into a large (>1 MDa) complex residing at 
the inner membrane/outer membrane interface (John et al., 2005). Also, it was shown 
to interact with six other proteins: Metaxin 1, Metaxin 2, SAM50, CHCHD6, 
DnaJC11, and CHCHD3 (Xie et al., 2007).  Metaxins 1 and 2 are cytosolic proteins, 
which associate with the mitochondrial outer membrane and are involved in protein 
import to the mitochondria (Abdul et al., 2000). SAM50, component of the outer 
membrane SAM complex is also involved in protein import and biogenesis, whereas 
DnaJC11 is a member of the 40 kDa heat shock protein family and may be involved in 
protein import and folding (Xie et al., 2007). The evidence of Mitofilin interaction 
with the Metaxins, SAM50, and DnaJC11, thus links cristae junction formation with 
mitochondrial protein import. Moreover, CHCHD6 has been recently described to take 
part in the regulation of mitochondrial cristae morphology, cell growth, ATP 
production and oxygen consumption (An et al., 2012).  
 
In addition, CHCHD3 is critical for cristae structure (Darshi et al. 2011). The 
protein is highly conserved in mammals with no homologs found in fungi or plants. 
Knockdown of CHCHD3 resulted in fragmented cristae or even their complete loss. 
Moreover, the average opening diameter of cristae junctions was reduced by 50% but 
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number of cristae junction was not affected, indicating a possible role of CHCHD3 in 
cristae junction architecture and maintenance rather than formation (Darshi et al., 
2011).    
 
All together, Mitofilins (Mitofilin/ Fcj1/ IMMT-1, IMMT-2) may control the 
formation of cristae junctions by inhibiting excessive growth and expansion of the 
inner membrane (John et al., 2005, Rabl et al., 2009, Mun et al., 2010). By forming a 
multimeric complex via homotypic interactions, they may form a filamentous scaffold, 
which supports the inner membrane and prevents its expansion (John et al., 2005, Xie 
et al., 2007, Mun et al., 2010). Evidence of Mitofilin interaction with the Metaxins and 
SAM50, not only links the cristae maintenance machinery with mitochondrial protein 
import, but also connects the inner membrane with the outer membrane, an interaction 
which may further support a rigid scaffolding model in maintenance of mitochondrial 
inner membrane architecture.   
 
The overall shape of the mitochondrial reticulum is dependent on continuous 
mitochondrial fission and fusion processes, which regulate mitochondrial morphology 
and number. Mitochondrial fission in yeast is dependent on the evolutionary conserved 
GTPase Fzo (Mfn in mammals), Ugo1, as well as Mgm1 (OPA1 in mammals) 
(Okamato and Shaw, 2005). OPA1/Mgm1, a large dynamin related GTPase, is 
anchored at the cristae junctions and exposed to the IMS (Olichon et al., 2002). 
Mitochondria with mutated or depleted OPA1/Mgm1 in yeast or HeLa cultured cells 
have fragmented spherical mitochondria with characteristically simple inner membrane 
organization, an effect of disrupted mitochondrial fusion (Olichon et al., 2002; 
Griparic et al., 2004; Mannella 2008). Moreover, depletion of OPA1 leads to the 
formation of aberrant curved vesicle-like cristae (Olichon et al., 2002). Besides its role 
in maintenance of the mitochondrial inner membrane, OPA1 has a role in apoptosis. 
Fragmentation of mitochondria during apoptosis is dependent on the proteolytic 
processing of OPA1 (Duvezin-Caubet et al., 2006), whereas a loss of OPA1 commits 
cells to apoptosis in the absence of further stimuli (Olichon et al., 2003). The role of 
OPA1 in apoptosis is proposed to involve cytochrome c sequestration and 
compartmentalization within the cristae membrane (Olichon et al., 2003). This may be 
mediated by OPA1 localization to the inner membrane and its control of cristae 
junction openings, hence preventing premature release of cytochrome c in the absence 
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of apoptotic stimuli (Frezza et al., 2006). Interestingly, OPA1 function links cristae 
biogenesis and apoptosis, which includes extensive remodeling of the cristae 
membrane (Scorrano et al., 2002).  This relationship is further exemplified by protein 
MICS1 that is involved in both maintenance of mitochondrial morphology and 
cytochrome c release during apoptosis (Oka et al., 2008).  MICS1-depleted 
mitochondria, like OPA1/Mgm1 mutants, had curved vesicle-like cristae (Oka et al., 
2008).  
 
Mgm1 has been described to have a chaperone-like function of the 
F1FOATPase dimerization factor Atp21, in which the loss of Mgm1 inhibits 
F1FOATPase dimerization (Amutha et al., 2004). This effect on dimerization might 
explain cristae membrane anomalies of Mgm1/OPA1 mutants (Mannella, 2008).  
Moreover, OPA1 has been shown to exist in a complex containing Mitofilin and 
SAM50, further advocating its role in the regulation of cristae morphology (Darshi et 
al., 2011). This is further exemplified by the observation that depletion of Prohibitins 
(proteins involved in regulation of OPA1) leads to loss of cristae (Osman et al., 2009; 
Zick et al., 2009). Overall, OPA1/Mgm1 demonstrates a role in mitochondrial fusion 
in cristae morphology. In addition, loss of cristae is observed in mutants of Mdm33, a 




2.11 Models of cristae biogenesis  
Evidently, various proteins integrally or peripherally associated with the mitochondrial 
inner membrane are involved in the biogenesis and maintenance of cristae membrane. 
The differences in the inner membrane morphologies of different mutants highlight the 
differences in the various proteins’ functions exemplified by their different 
localizations (Figure 7). F1FOATPase dimers favor positive curvature and are vital for 
cristae membrane tip formation, whereas Mitofilin/Fcj1 and OPA1 are required for 
cristae junction maintenance. The processes governing cristae morphology yet appear 
to be interconnected by dependence of Atp21 on OPA1/Mgm1 (Amutha et al., 2004) 
and modulation of Mitofilin/Fcj1 or F1FOATPase oligomerization  (Rabl et al., 2009).  
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Figure 7. Overview of factors involved in cristae biogenesis and maintenance. The import 
translocases (TOM and TIM) are found at the IBM, whereas the respiratory chain is found at 
cristae membranes. The F1FOATPase is located at cristae tips/apex and contributes to cristae 
shape. Mitofilin and OPA1 are located at cristae openings and control cristae junction width. 




With respect to cristae, various theoretical models have been proposed to explain 
cristae biogenesis, illustrated in Figure 8, as reviewed by Zick et al. (2009). 
Consideration of these models may provide explanations for the various aberrant 
phenotypes of mitochondrial morphology mutants. 
 
A) Invagination model / Late cristae junction model  
This model postulates that bending energy is sufficient to form spontaneous 
invaginations of the inner membrane giving rising to cristae membranes provided the 
continuous biogenesis of the inner membrane and a constant outer membrane surface 
(Renken et al., 2002).  The proposed bending energy can be derived from lipid 
composition and/or curvatures mediated by large protein complexes such as the 
F1FOATPase dimer (Paumard et al., 2002a). Consequently, cristae junctions are 
formed once cristae membrane tips are made.  
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B) Balloon model / Early cristae junction model  
Stable ring-like nascent cristae junction structures are formed at the IBM. Cristae are 
then formed by invagination, in which the nascent cristae junction structures act as an 
entry point for lipids and proteins (Zick et al., 2009).  
C) De novo vesicle germination model 
Cristae membranes are formed from mitochondrial matrix vesicles that are formed ‘de 
novo’ from single phospholipids particles that later fuse to the IBM (Zick et al., 2009). 
D) Cristae fusion/fission model  
This model proposes that cristae formation is dynamic, in which cristae membrane 
vesicles may continuously fuse from one side of the inner membrane to another 
(fission/fusion). Moreover, the observation that cristae morphology changes under 
different physiological conditions in a reversible manner supports dynamic rather than 
static nature of cristae propagation (Mannella et al., 2001).    
E) Fusion remnant model  
This model proposes that during mitochondrial fusion, cristae junctions initially 
formed when the inner membrane of two mitochondria fuse together. Cristae 
membranes are thus remnants of the fusion event. Membrane remodeling is then 
required to induce curvatures leading to a tubular cristae membrane structure.  
F) Hemifusion model  
Similar to the ‘fusion remnant’ model, cristae membranes are formed in events 
following mitochondrial fusion. The site, at which two opposing inner membranes 
fuse, forms a phospholipids vesicle in the matrix, thus also combining the ‘de novo 
vesicle germination model’. Once the vesicle is formed, it fuses to the IBM to form 
cristae.  This model makes the assumption that inner mitochondrial fusion is mediated 
by hemi-fusion, a membrane fusion intermediate formed when leaflets of two opposing 
membranes merge while distal remain distant (Chernomordik and Kozlov, 2005). 
Hemi-fusion allows the formation of the cristae-vesicle. 
 





Figure 8. Hypothetical models of cristae biogenesis. Adapted from Zick et al. (2009). IM, 
inner membrane; M, matrix.  
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2.12 Aims of this study  
Structural subunits of the F1FOATPase are involved in dimerization (Soubannier et al., 
2002; Fronzes et al., 2003). In addition, small FO associated yeast proteins (Atp18, 
Atp19, Atp20, and Atp21) mediate dimerization in yeast (Arnold et al., 1997, 1998; 
Soubannier et al., 2002; Paumard et al., 2002a; Wagner et al., 2009, 2010). However, 
their presence does not seem to be conserved in higher eukaryotes. To this end, the aim 
of this study is to identify novel F1FOATPase dimerization factors in higher 
eukaryotes. For this purpose, an in silico based search will be used. The bioinformatics 
approach will be based on searching yeast open reading frames (ORFs) with human 
homologs. The search will also take into account the various characteristics of known 
dimerization factors. Mitochondria isolated from human cultured cells (HEK29T) cells 
will be used to analyze putative F1FOATPase dimerization factors. On the other hand, 
mitochondria isolated from S.cerevisiae will be used to analyze the yeast homologs. 
Once identified, putative factors will be characterized for possible functions in 
dimerization. As the F1FOATPase dimerization factors are membrane proteins (Wagner 
et al., 2010), putative dimerization factors will be tested first for their membrane 
association.  A role in dimerization will be assessed by investigating F1FOATPase 
interaction and by analyzing the various available yeast mutants.  In addition, as the 
absence of the dimerization factors Atp20 and Atp21 lead to various aberrations in 
cristae morphology (Paumard et al., 2002b; Arselin et al., 2003; Arselin et al., 2004), a 
role in mitochondrial architecture that putative dimerization factors might have will 
also be considered. 
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3.1.1 Chemicals  
Product   Supplier  
Acetone AppliChem (Steinheim, Germany) 
Acetic acid Roth (Karlsruhe, Germany) 
Acrylamide/ Bisacrylamide solution Roth (Karlsruhe, Germany) 
Agar-Agar Roth (Karlsruhe, Germany) 
Adenosine triphosphate (ATP) Sigma (Steinheim, Germany) 
Agarose NEEO Ultra-Qualität Roti®garose Roth (Karlsruhe, Germany) 
Ammonium acetate Merck (Darmstadt, Germany) 
Ammoniumpersulsulfate (APS) Merck (Darmstadt, Germany) 
Ampicillin AppliChem (Steinheim, Germany) 
Bacto™Peptone BD (Sparks, USA) 
Bacto™ Tryptone BD (Sparks, USA) 
Bacto™ Yeast Extract BD (Sparks, USA) 
Bis-Tris Roth (Karlsruhe, Germany) 
Bovine serum albumin (BSA)  Sigma (Steinheim, Germany) 
Bradford-Reagent Bio-rad (Richmond, USA)  
Bromophenoblue Merck (Darmstadt, Germany) 
6-amino Caproic acid Sigma (Steinheim, Germany) 
Coomassie Brilliant Blue G-250 Serva (Heidelberg, Germany) 
Coomassie Brilliant Blue R-250 Serva (Heidelberg, Germany) 
Complete Supplement Mixture – Uracil  
(CSM-URA) 
MP Biomedicals (Eschwege, 
Germany) 
Creatine Phosphate Roche (Manheim, Germany) 
L-Cysteine.HCl Merck (Darmstadt, Germany) 
Cytochrome c (bovine heart) Sigma (Steinheim, Germany 
Desthio-Biotin IBA GmbH (Göttingen, Germany) 
3,3’ Diaminobenzidine (DAB) Sigma (Steinheim, Germany 
Digitonin  Calbiochem (La Jolla, U.S.A) 
Dimethyl pimelimidate dihydrochloride (DMP) Sigma (Steinheim, Germany) 
Dimethylsulfoxide (DMSO) Applichem (Darmstadt, Germany) 
Dipotassium hydrogen phosphate Roth (Karlsruhe, Germany) 
Dithiothreitol (DTT) Roth (Karlsruhe, Germany)  
Dulbecco’s Modified Eagle Medium  (DMEM)  Gibco (Karlsruhe, Germany) 
Ethidium bromide AppliChem  
Ethylenediaminetetraacetic acid (EDTA)  Roth (Karlsruhe, Germany) 
Glucose Roth (Karlsruhe, Germany) 
Glycerin Roth (Karlsruhe, Germany) 
Glycin Roth (Karlsruhe, Germany) 
Glycerol  Sigma (Steinheim, Germany) 




HEPES Roth (Karlsruhe, Germany) 
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Herring sperm Promega (Mannheim, Germany) 
Lead(II) nitrate Pb(NO3)2 Sigma (Steinheim, Germany) 
Magnesium acetate Merck (Darmstadt, Germany) 
Magnesium chloride (MgCl2) Merck (Darmstadt, Germany) 
Magnesium sulfate (MgSO4) Roth (Karlsruhe, Germany) 
ß-Mercaptoethanol Sigma (Steinheim, Germany) 
Methanol Roth, (Karlsruhe, Germany) 
Milk Reformhaus (Essen, Germany) 
L-Methionine Serva (Heidelberg, Germany) 
3-(N-morpholino) propanesulfonic acid 
(MOPS) 
Sigma (Steinheim, Germany) 
Lithium acetate Applichem (Darmstadt, Germany) 
Nicotinamide adenine dinucleotide hydrate 
(NADH) 
Roche (Manheim, Germany) 
4-Nitrotetrazoliumchrolide blue (NBT) Sigma (Steinheim, Germany) 
N,N,N’,N’-Tetramethylethylene diamine 
(TEMED) 
Roth (Karlsruhe, Germany) 
Polyethylene glycol 4000 (PEG-4000) Merck (Darmstadt, Germany) 
PMSF  Roth (Karlsruhe, Germany) 
Potassium acetate Merck (Darmstadt, Germany) 
Potassium chloride Roth (Karlsruhe, Germany) 
Potassium dihydrogen phosphate Merck (Darmstadt, Germany) 
Sodium borat Sigma (Steinheim, Germany) 
Sodium azide Sigma (Steinheim, Germany) 
Sodium Chloride Roth (Karlsruhe, Germany) 
Sodium deoxycholate Sigma (Steinheim, Germany) 
Sodium-dithionite (Na-dithionite) Fluka (Steinheim, Germany) 
Sorbitol MP Biomedicals (Illkirch, France) 
SDS Roth (Kalrsruhe, Germany) 
Tricine Roth (Karlsruhe, Germany) 
Trifluoroacetic acid (TCA) Merck (Darmstadt, Germany) 
Tris(hydroxmethlyl)-aminomethane (Tris), Roth (Karlsruhe, Germany) 
Triton X-100 Sigma (Steinheim, Germany) 
Tween-20 Roth (Karlsruhe, Germany) 
Yeast Nitrogen base Difco BD (New Jersey, USA) 
L-uracil Sigma (Steinheim, Germany) 
 
3.1.2 General buffers and solutions 
Buffer  Recipe  
SDS-PAGE sample buffer 2% SDS, 10% Glycerol, 60 mM Tris pH 6.8, 
1% ß-mercaptoethanol, 0.01% 
Bromophenolblue  
SDS-PAGE running buffer 25 mM Tris pH 6.8, 190 mM Glycine, 1% (w/v) 
SDS 
SDS-PAGE resolving gel buffer 1.87 M Tris pH 8.8 
SDS-PAGE stacking gel buffer  0.8 M Tris pH 6.8  
Transfer/Blot Buffer 20 mM Tris 
150 mM Glycin  
0.02% SDS  
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20% Methanol or Ethanol 
3x BN-PAGE gel Buffer 200 mM 6-amino caproic acid 
150 mM Bis-Tris /HCl pH 7.0 
40x BN-PAGE Anode Buffer 2 M Bis-Tris / HCl pH 7.0 
10x BN-PAGE Cathode Buffer 500 mM Tricine pH 7.0 
150 mM Bis-Tris 
0.2% Coomassie blue G250  
10x BN Loading Dye  5% Coomassie blue G250 
500 mM 6-amino caproic acid  
100 mM Bis-Tris pH 7.0  
10X TBS  200 mM Tris-HCl pH 7.5 
1.25 M NaCl 
TBS-T 1x TBS 
0.1% Tween-20 
TE buffer 10 mM Tris-Cl, pH 7.5. 1 mM EDTA 
 
Standard Import Buffer  3% (w/v) fatty acid free BSA 
250 mM sucrose  
80 mM KCl 
5 mM MgCl2 
2 mM KH2PO4  
5 mM methionine  
10 mM MOPS-KOH pH 7.2 
SEM Buffer 250 mM sucrose 
1 mM EDTA 
10 mM MOPS pH 7.2 
KPi Buffer  20 mM NaH2PO4/Na2HPO4  
10x PBS Buffer 1 M Tris  
1 M Boric Acid 
20 mM EDTA  
Gel Staining Solution  MeOH 40% (v/v), Acetic acid 10% (v/v), H20 
50% (v/v) 
Coomassie Serva Blue R250 0.15% 
Gel Destaining Solution MeOH 40% (v/v), Acetic acid 10% (v/v), H20 
50% (v/v)  




3.1.3 Instruments  
 
3.1.3.1 Centrifuges  
Product Supplier  
5417R centrifuge Eppendorf (Hamburg, Germany)  
5424 centrifuge Eppendorf (Hamburg, Germany)  
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5804R centrifuge Eppendorf (Hamburg, Germany)  
Sorvall RC 6 Plus Thermo Scientific (Bad Homburg, Germany) 
Sorvall RC 12BP Thermo Scientific (Bad Homburg, Germany) 
J2-MC Beckman Coulter (Palo Alto, USA)  
Optima ™ MAX ultracentrifuge Beckman Coulter (Palo Alto, USA) 
 
3.1.3.2 Rotors 
Product Supplier  
F45-30-11 Eppendorf (Hamburg, Germany) 
F45-24-11 Eppendorf (Hamburg, Germany) 
A-4-44 Eppendorf (Hamburg, Germany) 
Sorvall F14S-6x250Y  Thermo Scientific  (Bad Homburg, Germany) 
Sorvall SS-34  Thermo Scientific (Bad Homburg, Germany) 
Sorvall F10S-6x500Y Thermo Scientific (Bad Homburg, Germany) 
Sorvall H-12000 Thermo Scientific (Bad Homburg, Germany) 
JA-20 Beckman Coulter (Palo Alto, USA) 
TLA-55 Beckman Coulter (Palo Alto, USA) 
 
3.1.3.3 Gel systems and Power supply 
Product Supplier  
Mini PROTEAN ® Tetra Cell  Bio-Rad (Richmond, USA) 
Mini-Sub cell GT Bio-Rad (Richmond, USA)  
Hoefer SE 600 Ruby ™ 
electrophoresis unit 
GE Healthcare (Buckinghamshire, UK) 
EPS-601 power supply GE Healthcare (Buckinghamshire, UK) 
GIBCO-BRL power supply 250EX Life Technologies (Karlsruhe, Germany) 
Ecoline Staredition RE107 Lauda (Lauda-Königshofen, Germany) 
GD5040 gel dryer Scie-PLas (Warwickshire, UK) 
UV100 Transilluminator Biometra (Göttingen, Germany) 
T1 1 UV transilluminator Biometra (Göttingen, Germany) 
 
3.1.3.4 Photometers 
Product Supplier  
Carry50 Bio UV/visible 
Spectrophotometer 
Varian Inc (Palo Alto, USA)  
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Biophotometer Eppendorf (Hamburg, Germany) 




Product Supplier  
G25 Incubator shaker New Burnswick Scientific Co. (Nürtingen, 
Germany) 
innova®44 incubator shaker New Burnswick Scientific Co. (Nürtingen, 
Germany) 
innova®2300 platform shaker New Burnswick Scientific Co. (Nürtingen, 
Germany) 
Excella E10 platform shaker New Burnswick Scientific Co. (Nürtingen, 
Germany) 
Polymax 1040 shaker Heidolph (Schwabach, Germany) 
Shaker DRS-12 ELMI (Riga, Latvia) 
 
3.1.3.6 Other instruments 
Product Supplier  
Thermomixer Comfort Eppendorf (Hamburg, Germany) 
Savant SpeedVac concentrator GMI (Ramsey, USA) 
Vortex-GenieZ Scientific Industries (New York, USA) 
T-personal PCR machine Biometra (Göttingen, Germany) 
pH meter inoLab (Straubing, Germany) 
Potter S homogenizer Sartorius (Göttingen, Germany)  
Storm™ 820 PhosphorImager GE Healthcare (Buckinghamshire, UK) 
Fluorescence scanner FLA-9000 Fujifilm (Düsseldorf, Germany) 
ÄKTApurifier system GE Healthcare (Münich, Germany) 
Superose 6 10/300 GL GE Healthcare (Münich, Germany) 
LAS 3000  Fujifilm (Düsseldorf, Germany) 
 
3.1.4 Kits 
Product Supplier  
Wizard® Plus SV Minprep DNA 
Purification System 
Promega (Madison, USA) 
Wizard® SV gel and PCR clean up 
System 
Promega (Madison, USA) 
HiSpeed ® Plasmid Midi Kit Qiagen (Hilden, Germany) 
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mMessage mMachine SP6 Ambion® (Austin, USA) 
MEGAclear™ Purification of 
Transcription Reaction 
Ambion®  (Austin, USA) 
Amersham™ Rabbit Reticuloycte 
Lysate System for in vitro 
translation 
GE Healthcare (Buckinghamshire, UK) 
 
Amersham™ ECL™ GE Healthcare (Buckinghamshire, UK) 
Mobicol columns MoBiTec (Göttingen, Germany) 
Disposable Polypropylene 
Columns 
Thermo Scientific (Bad Homburg, Germany) 
Sulfolink Coupling Gel  Pierce (Rockford, USA) 
ABI PRISM® BigDye® 
Terminator v1.1 Cycle Sequencing 
Kit 
Applied Biosystems (Darmstadt, Germany) 
 
KOD HotStart DNA polymerase Novagen, Merck (Darmstadt, Germany) 
 
3.1.5 Enyzmes  
Product Supplier  
Restriction Endonucleases New England Biolabs (Ispwich, USA) 
DNaseI Roche (Manheim, Germany) 
T4 DNA Ligase New England Biolabs (Ispwich, USA) 
Zymolyase Seikagaku Biobusiness (Tokyo, Japan)  
Proteinase K (PK) Roche (Manheim, Germany) 
Creatine Kinase (CK) Roche (Manheim, Germany) 
 
3.1.6 Antibodies  
Table 1. Details of various antibodies used in this study  
Primary Antibody Organism Source 
α-Atp2 Yeast AG Rehling (861) 
α-ATP2 Human Invitrogen 
α-Atp5 Yeast AG Rehling (1546) 
α-Atp20 Yeast AG Rehling (1517) 
α-CHCHD3 Human Abcam 
α-Cox1 Yeast AG Rehling (1538) 
α-Cox2 Yeast AG Rehling (1948) 
α-Cox4 Yeast AG Rehling (578) 
α-COX6A1 Human AG Rehling (3283) 
α-COX Human Invitrogen 
α-Cyt1 Yeast AG Rehling (540) 
α-F1FOATPase Human Invitrogen 
α-Fcj1 Yeast AG Rehling (857)  
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α-HSPA9 Human Abcam 
α-Hsp70 Yeast AG Rehling (657) 
α-IMMT (Mitofilin) Human Abcam 
α-MINOS1 Human Abcam 
α-Mio10  Yeast AG Rehling (3459) 
α-TACO1 Human AG Rehling (3627) 
α-Tim21  Yeast AG Rehling (258) 
α-TIM23 Human AG Rehling (1526) 
α-Tom70 Yeast AG Rehling (657) 
α-TOM70 Human AG Rehling (3280) 
α-Rip1 Yeast AG Rehling (543) 
   
Secondary Antibody Organism Source 
Goat α-Rabbit - Dianova 
Alexa Fluor  - Inivitrogen 
 
 
3.1.7 Yeast strains 
 
Table 2. Details of yeast strains used in this study including genotype and source. 
Strain Genotype Source 
BY4741 Mat a, his3-∆1 leu2∆0 met15∆0 ura3∆0 Sikorski and Hieter, 
1989 
YPH499 Mat a, ade2-101 his3-∆200 leu2-∆1 ura3-52 
trp1-∆63 lys2-801 
Sikorski and Hieter, 
1989 
atp20∆ Mat a, his3-∆1 leu2∆0 met15∆0 ura3∆0; 
atp20::kanMX4 
Open Biosystems 
atp2∆ Mat a, his3-∆1 leu2∆0 met15∆0 ura3∆0; 
atp2::kanMX4 
Open Biosystems 
fcj1∆  Mat a, his3-∆1 leu2∆0 met15∆0 ura3∆0; 
fcj1::kanMX4 
Open Biosystems 
Fcj1ZZ Mat a, ade2-101 his3-∆200 leu2-∆1 ura3-52 
trp1-∆63 lys2-801; fcj1::FCJ1-ZZ-HIS3MX6 
Von der Malsburg et 
al., 2011; Alkhaja et 
al., 2012 
mio10∆ Mat a, his3-∆1 leu2∆0 met15∆0 ura3∆0; 
mio10::kanMX4 
Open Biosystems 
Atp20ZZ Mat a, ade2-101 his3-∆200 leu2-∆1 ura3-52 
trp1-∆63 lys2-801; atp20::ATP20-ZZ-
HIS3MX6 
This study; Alkhaja 
et al., 2012 
Atp5SF Mat a, ade2-101 his3-∆200 leu2-∆1 ura3-52 
trp1-∆63 lys2-801; atp5::ATP5-SF-HIS3MX6 
This study 




Mio10SF  Mat a, ade2-101 his3-∆200 leu2-∆1 ura3-52 
trp1-∆63 lys2-801; mio10::MIO10-SF-
HIS3MX6 
This study; Alkhaja 
et al. 2012 
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3.1.8 Yeast growth medium 
Medium Recipe 
YPG 1% (w/v) yeast extract 
2% (w/v) bactopeptone 
3% (w/v) glycerol 
YPD 1% (w/v) yeast extract 
2% (w/v) bactopeptone 
2% (w/v) glucose 
YPS 1% (w/v) yeast extract 
2% (w/v) bactopeptone 
2% (w/v) sucrose  
SD 0.67% (w/v) yeast nitrogen base 
0.7% (w/v) drop out mix of CSM-URA  
20 µg/ml uracil 
2% (w/v) glucose  
SG 0.67% (w/v) yeast nitrogen base 
0.7% (w/v) drop out mix of CSM-URA  
20 µg/ml uracil 
2% (w/v) glucose 
 
 
3.1.9 Bacterial medium  
LB medium 1% (w/v) tryptone 
0.5% (w/v) yeast extract 
170 mM NaCl  
LB-Agar Plates  LB medium with 1.5% (w/v) agar  
 
3.1.10 Bacterial strains  
 
XL1-Blue SupE44 hsdR17 recA1 endA1 gyrA46 thi relA1 lac-
F’[proAB+lacIq lacZ∆M15 Tn10(tetr)]  
 
 
3.1.11 Miscellaneous products 
Product Supplier  
Polyvinylidene difluoride (PVDF) 
membranes Millipore (Schwalbach, Germany) 
Whatman paper Heinemann (Schwäbisch Gmünd, Germany) 
Protein Standards SDS-PAGE Bio-Rad (Richmond, USA) 
Protein Standards BN-PAGE Amersham, GE Healthcare (Buckinghamshire, 
USA) 
GeneLadder™ DNA Marker Fermentas, Thermo Fisher (Bad Homburg, 
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Germany) 
Falcon tubes  BD Biosciences Cell Culture (Sparks, USA) 
Eppendorf tubes Eppendorf (Hamburg, Germany) 
Strep-Tactin Sepharose IBA GmbH (Göttingen, Germany)  
Strataclean  
 
Agilent Technologies (Santa Clara, USA) 
IgG Sepharose GE Healthcare (Buckinghamshire, UK) 
FLAG Agarose Sigma (Steinheim, Germany) 
Flag peptide Sigma (Steinheim, Germany) 
Protein A Sepharose (PAS) Pierce (Rockford, USA) 
 
3.2 Growth of biological systems  
3.2.1 Cultivation of bacteria  
Bacteria were cultivated under standard conditions at 37°C with addition of 
appropriate antibiotics. Ampicillin was added to a final concentration of 100 mg/L.  
 
3.2.2 Cultivation of yeast  
For precultures, yeast colonies were picked and incubated in a 5-10 ml YPD preculture 
in a shake flask and incubated with vigorous shaking overnight at 30°C. This culture 
was then used to inoculate main cultures in appropriate medium in shake flasks for 
various applications with varying final OD600. 
 
3.2.3 Yeast cryo stock 
Yeast strains were preserved as cryo stocks containing YPAD medium (1% yeast 
extract, 2 % peptone, 0.003% adenine sulfate, 2% glucose, and 15% glycerol). Yeast 
cells grown on plate were mixed with YPAD medium in previously autoclaved cryo 
tubes and stored at -80°C. 
 
3.2.4 Growth analysis of yeast  
Yeast growth tests were performed by adjusting cultured yeast to an OD600 of 0.1 and 
spotting of serial dilutions onto agar plates containing 1% yeast extract, 2% peptone, 
with 3% glycerol (for YPG) or 2% glucose (YPD). Alternatively, plates containing 
synthetic medium were used: 0.67% yeast nitrogen base (Difco, BD), 0.7 g/l drop-out 
mix of CSM-URA (MP biomedicals), 20 µg/ml of uracil, supplemented with 2% 
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glucose (SD) or 3% gylcerol (SG). 
 
3.2.5 Cultivation of HEK293T cells 
HEK293T cells were cultured under standard condition in Dulbecco’s Modified Eagle 
Medium containing 10% fetal bovine serum at 37°C and 5% CO2. For SILAC analysis, 
cells were grown in lysine- and arginine-deficient DMEM Medium supplemented with 
10 % fetal bovine serum. Light labeled medium was supplemented with normal 
isotope containing L-lysine and L-arginine, whereas heavy labeled medium was 
supplemented with heavy isotope labeled 13C615N2-lysine and 13C615N4-arginine 
(Euriso-Top, Germany).  
 
3.3 Molecular Biology Techniques  
3.3.1 PCR amplification 
PCR amplification was performed using yeast genomic DNA and the KOD HiFi DNA 
polymerase (KOD HotStart, Novagen).  
 
3.3.2 Determination of nucleic acid concentrations  
DNA and RNA concentrations were determined photometrically using NanoVue (GE 
Healthcare). In brief, 1-2 µl of nucleic acid was added to the NanoVue and quantified 
accordingly at appropriate wavelength and settings.  
 
3.3.3 DNA electrophoresis 
PCR products and plasmids were analyzed by agarose gel electrophoresis. In brief, a 
gel solution composed of 0.7-1.2% (w/v) agarose (Agarose NEEO Ultra-Roti, Roth) in 
1x TAE buffer gel solution with ethidium bromide was prepared and poured into UV-
transparent gel trays inserted into the gel casters. Gel solutions were allowed to 
polymerize after the addition of well forming combs. After loading all test samples and 
DNA size marker (Geneladder™ DNA Marker Mix, Fermentas), gels were subjected 
to a voltage of 100-120 mV. Upon completion of electrophoresis, a UV100 
Transilluminator or alternatively a Biometra T1 1 UV transilluminator was used to 
visualize DNA.   
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3.3.4 Sequencing DNA 
Sequencing was performed by dideoxy chain termination method (Sanger et al., 1977). 
DNA template or plasmid samples were combined with 8 pmol PCR primer, 15% v/v 
sequencing mix and 15% v/v sequencing buffer (ABI PRISM® BigDye® Terminator 
v1.1 Cycle Sequencing Kit). For sequencing templates from PCR products, the 
sequencing mix and sequencing buffer solutions were reduced to 10% v/v. Templates 
were amplified by PCR for 25-30 cycles (96°C melting for 10 seconds, 55°C annealing 
for 15 seconds and extension at 60°C for 4 minutes) and consequently precipitated in 
48 mM EDTA, 80% ethanol followed by washing with 70% ethanol and drying DNA 
pellets in a SpeedVac for 2 minutes. Dried pellets were resuspended in 15 µl 
formadine (HiDye). Samples were analyzed by a Genetic Analyzer 3100 (Applied 
Biosystems) and DNA sequences analyzed by the program ApE (M. Wayne Davis).   
 
3.3.5 Transformation of E.coli 
Frozen heat-competent bacteria cell were thawed on ice and mixed with 30 ng DNA 
and incubated for 20 minutes. Cells were then heat-pulsed at 42°C for 45 seconds 
before a further 2 minute incubation on ice. Pre-warmed LB medium was added to 
each sample (9x volume) and cells were incubated for 1 hour at 37°C with gentle 
shaking. Approximately 100 µl of each transformation was plated on LB agar plates 
containing appropriate antibiotic (Ampicillin + LB agar plates with 100 mg/L 
Ampicillin). Plates were incubated overnight at 37°C or until appearance of colonies. 
 
3.3.6 Transformation of yeast 
Yeast cells grown overnight in YPD were pelleted and washed with distilled H2O 
before treatment with 0.1 M lithium acetate to generate transformation competent 
cells. Transformation reactions were carried out by the addition of: 10% (v/v) carrier 
DNA (Herring sperm) and 5-10% (v/v) PCR product or alternatively 2% (v/v) plasmid 
and mixed with 5x volume of 40% PEG-4000 in lithium acetate. Samples were 
incubated for 30 minutes at 30°C after which, DMSO was added to a final 
concentration of 10% (v/v) and samples incubated for a further 20 min at 42°C with 
gentle shaking. After incubation, samples were centrifuged at 4000 rpm for 5 min. 
Pellets were resuspended in YPD and incubated with shaking for 2-4 hours at 30°C 
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and then washed with distilled H2O before plating on selective medium plates and 
incubated at 30°C until appearance of colonies.   
 
3.3.7 Yeast genomic DNA preparation 
Yeast cells were grown to an OD600 of 0.5-0.7, pelleted, and resuspended in Solution A 
(50 mM Tris/HCL pH 7.5, 10 mM EDTA, 0.3% ß-mercaptoethanol, 0.5-0.25 mg/ml 
Zymolyase) and incubated for 1 hour at 37°C. Consequentially, SDS was added to a 
final concentration of 1% (v/v) together with ammonium acetate and incubation at -
20°C for 15 min. Samples were pelleted, and approximately 66% of the supernatant 
was saved and incubated with isopropanol (40% v/v). Samples were again centrifuged 
and the resulting pellet was washed in 70% ethanol and dried. The dried pellet was 
finally resuspended in TE buffer.  
 
3.4 Protein Biochemistry  
 
3.4.1 TCA precipitation  
Samples were treated with 0.2x of final volume with 72% TCA (w/v) stock solution 
and 0.01x (1/100) of sodium deoxycholate (1.25% stock solution). All samples were 
incubated 30 min on ice followed by centrifugation at 4°C for 30 min. The resulting 
pellets were washed with 500 µl ice-cold acetone followed by centrifugation at 4°C for 
30 min. Pellets were dried at 37°C for 5-10 min and then resuspended in 1x SDS-
PAGE sample buffer and incubated at 60°C for 15 min before SDS-PAGE analysis.  
 
3.4.2 Whole cell extracts 
Cultured yeast cells, grown to an OD600 of 3, were pelleted, and resuspended in 1 ml 
H2O with 250 mM NaOH and 1% (v/v) β-mercaptoethanol. Following a 10 min 
incubation on ice, proteins were TCA precipitated by the addition of 6% (v/v) TCA 
and incubation at 10 min on ice, followed by centrifugation at 14,000 rpm at 4°C. The 
protein containing pellet was further resuspended in SDS sample buffer and pH titrated 
with 1 M Tris-Base, followed by incubation at 60°C before subjecting samples to 
SDS-PAGE analysis.   
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3.4.3 SDS-PAGE analysis 
For SDS-PAGE, components were mixed as shown in Table 3. Glass walls, spacers 
and combs were cleaned with 70% ethanol and assembled on a holder. A separating 
gel was poured between two glass plates and overlain with isopropanol until 
polymerized followed by pouring of the stacking gel and insertion of appropriate 
combs. After polymerization, combs were removed and the gel apparatus was placed 
into an electrophoresis chamber filled with running buffer. Large gels were run at a 
constant current of 30 mA and 220 mV, whereas Mini-gels were run a constant current 
of 25 mA and 100 mV. For the analysis of Mio10 import, a Tricine-SDS PAGE was 
used (Schägger and von Jagow, 1987). A 48% w/v acrylamide, 1.5% w/v 
bisacrylamide solution was used. A 3x gel buffer (3 M Tris, 0.3%, pH 8.45 / HCl) in 
used in prepration of the gel which contained a 4% stacking, 16.5% separating gel, and 
a 10% spacer between stacking and separating gel. In addition, a 10x cathode buffer (1 
M Tris, 1 M Tricine, 1% SDS, pH 8.25) and a 10x anode buffer (2 M Tris, pH 8.9/ 
HCl) were used. Gels were run slowly overnight at 80 mV or 18 mA limiting.  
 
 
Table 3. SDS-PAGE pipetting scheme. Constituents of SDS gel were added as 
indicated to make 1 SDS-PAGE gel.  
 
 Resolving Gel Stacking Gel 
% Acrylamide 14% 12.5%   
Acrylamide/ bisacrylamide  
(30/0.8) 
7.9 ml 6.9 ml 0.83 ml 
1.87 M Tris pH 8.8 3.5 ml 3.5 ml - 
0.8 M Tris pH 6.8 - - 0.5 ml 
10% (w/v) SDS 0.17 
ml 
0.17 ml 50 µl  
dH2O  5.3 ml 6.3 ml 3.55 ml 
10% (w/v) APS 100 µl 100 µl  50 µl  
TEMED 10 µl 10 µl 10 µl 
Total Volume 17 ml  17 ml  5 ml  
 
3.4.4 BN-PAGE Analysis  
3.4.4.1 First Dimension BN-PAGE 
Prior to gel pouring and preparation, all components shown in Table 4 except for APS 
and TEMED were mixed accordingly and stored at 4°C. Glass walls, spacers and 
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combs were cleaned with ethanol and assembled on a holder. A gradient separating gel 
was poured accordingly and overlain with isopropanol.  Stacking gel was poured and 
combs inserted. Polymerization of BN-PAGE gel was performed overnight at 4°C or 
alternatively for 1 hour at RT. BN-PAGE samples were loaded at 4°C and high-
molecular weight markers used, with 1x BN-PAGE loading dye used to fill in empty 
lanes. The gel apparatus is then transferred into the BN-PAGE electrophoresis 
chamber containing 4 L pre-cooled 1x Anode Buffer and 500 ml Cathode Buffer 
added. Gels were run at 4°C first at a constant voltage of 200 mV at the region of 
stacking gel and then 600 mV at the separating gel with a constant current of 30 mA. 
Alternatively, gels were set to 100 mV and run overnight. In the case of subsequent 
blotting, second dimension analysis or activity assays, the cathode buffer is exchanged, 
with 1x Cathode buffer containing no Coomassie Serva Blue G250, 1 hour after 
electrophoresis.  
 
3.4.4.2 Second Dimension BN-PAGE 
BN PAGE was performed as described above (with cathode buffer exchange). After 
electrophoresis gel stripes of individual lanes were excised accordingly and incubated 
in H2O. Gel stripes were then placed on the upper part of an SDS-PAGE glass plate, 
approximately 15 mm above the expected stacking/separating gel boundary. Glass 
plates were assembled and separating and stacking gel solutions were poured. A 2-3 
comb well was used to load markers and/or mitochondria controls. SDS-PAGE was 
performed as described above followed by Western blotting. 
 
Table 4. BN-PAGE pipetting scheme. Constituents of BN gel were added as 
indicated to make 1 BN-PAGE gel.  
 
 Resolving Gel Stacking Gel 
% Acrylamide 4 10 13  
3x Gel Buffer 3 ml 3 ml 3 ml 2.5 ml 
Acrylamide 0.73 ml 1.82 ml 2.35 0.6 ml 
Glycerol - 1.8 ml 1.8 ml -  
10% APS (w/v) 40 µl 40 µl 40 µl 30  
TEMED 4 µl 4 µl 4 µl 3 
dH2O 5.228 ml 2.347 ml 1.817 ml 4.367 
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3.4.5 Coomassie staining  
After electrophoresis, gels were stained in gel staining solution for 1 hour and then 
destained in gel destaining solution for 1 hour. 
 
3.4.6 Western blotting and immunodetection 
Western blots were performed with PVDF membranes and detected by enhanced 
chemiluminescence (ECL). In brief, PVDF membranes were incubated in methanol 
prior to blot and blotting was performed at 250 mA and 40V for 2 hrs. After blotting, 
PVDF membranes were incubated in Staining solution for 30 seconds and washed with 
Destaining solution. Marker bands were marked and membrane washed with 
Destaining solution and methanol until clear. For SDS-PAGE analysis, membranes 
were blocked with 5% Milk-TBST for 1 hour at RT and incubated with appropriate 
antibody for 1 hour at RT followed by 3 x 15 min washes with TBST. Secondary 
antibody was applied for 1 hour at RT followed by 3x 15 min washes with TBST, and 
finally detection was performed by ECL. For BN-PAGE immunodetection, 
membranes were blocked with 10% Milk-TBST for 4 hrs or overnight and primary 
antibody and secondary antibody incubations were for 1 hour each at RT and detection 
was by ECL and a film developing machine. Alternatively, fluorescently labeled 
antibodies were used and detection was performed with the fluorescence scanner 
(FLA-9000; Fujifilm). 
 
3.4.7 Size exclusion chromatography 
Solubilized yeast and human mitochondrial protein complexes were separated by gel 
filtration using an ÄKTApurifier system (GE Healthcare). In brief, 200 µg of isolated 
mitochondria were solubilized in 200 µl GF-buffer (20 mM Tris/pH7.4, 50 mM NaCl, 
0.5 mM EDTA, 10% (w/v) Glycerol, 1% (w/v) Digitonin, 1mM PMSF) for 20 min on 
ice. Samples were centrifuged, insoluble pellet discarded and resulting supernatants 
were loaded on a Superose 6 10/300 GL (GE Healthcare) equilibrated with GL-buffer 
(20 mM Tris/pH7.4, 50 mM NaCl, 0.5 mM EDTA, 10% (w/v) Glycerol, 0.1% (w/v) 
Digitonin). The resulting fractions from the ÄKTApurifier system were precipitated 
with TCA as described above with the exception of a further acetone wash prior to 
drying  and resolving samples in 1x SDS sample buffer. Samples were then analyzed 
by SDS-PAGE and Western blotting.  
                                                                                      MATERIALS AND METHODS  
 39 
3.4.8 Digital autoradiography  
For detection and analysis of radioactive signals by digital autoradiography, destained 
gels are first placed on Whatman paper, covered with a plastic sheet and dried for 2 
hours. After drying, markers on the gel are labeled with radioactive ink and covered 
with transparent tape. The gel is placed in an autoradiography cassette and film is 
exposed accordingly. 
 
3.4.9 Isolation of mitochondria from yeast 
3.4.9.1 Mitochondrial preparation YPG at 30°C  
Yeast mitochondria were isolated by differential centrifugation as described by 
Meisinger et al., 2006. For each strain, the preculture was used to inoculate 5.1-10.2 L 
medium to achieve an OD600 nm of 2.0, in which yeast should be a mid-log growth 
phase at time of harvest. Main cultures were grown for 15-18 hrs with vigorous 
shaking at 30°. Yeast cells were harvested by centrifugation at 4000 rpm in a RC 12BP 
Sorvall centrifuge for 20 min at 18°C and supernatant was discarded. The pellets were 
resuspended in water and combined in a F10S centrifugation tube, and centrifuged in a 
Sorvall F10S-6x500Y rotor at 4000 rpm for 10 min at 18°C. Supernatant was 
discarded and the weight of wet cell pellet was determined. The resulting cell pellets 
were resuspended in DTT buffer (100 mM Tris/HCl pH 9.4, 10 mM DTT) at a 
concentration of 2 ml per gram yeast and incubated with shaking at 30° C for 30 min. 
Cell suspensions were centrifuged in a Sorvall F10S-6x500Y rotor at 4000 rpm at 
18°C for 8 min. Supernatants were discarded and pellets were washed with 200 ml 1.2 
M Sorbitol and cell suspension was centrifuged at 4000 rpm at 18°C for 8 min (Sorvall 
F10S-6x500Y rotor). Supernatants were again discarded and pellets resuspended in 
zymolyase buffer (20 mM KPi Buffer, 1.2 M Sorbitol), supplemented with 4 mg 
zymolyase per gram of yeast. Cell suspensions were incubated with shaking at 30°C 
for 60 min and then centrifuged at 3000 rpm at 18°C for 10 min (Sorvall F10S-6x500Y 
rotor). Pellets were washed with zymolyase buffer without enzyme and centrifuged at 
3000 rpm at 18°C for 10 min (Sorvall F10S-6x500Y rotor). Supernatants were 
discarded and pellets were stored on ice and resuspended in Homogenization Buffer 
(0.6 M Sorbitol, 10 mM Tris/HCl pH 7.4, 1 mM EDTA, 0.2% (w/v) BSA) at a 
concentration of 7 ml per gram yeast. PMSF was added to a final concentration of 1 
mM to each suspension. Cells were homogenized by a Potter S Homogenizer and 
centrifuged in a Sorvall F15S-6x250Y rotor at 3000 rpm for 5 min at 4°C. Pellets were 
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discarded and supernatants were transferred into fresh F15S tubes and centrifuged at 
4000 rpm for 10 min at 4°C. Supernatants were discarded whereas pellets were pooled 
in SS-34 tubes and washed in 5 ml SEM Buffer with a final concentration of 1 mM 
PMSF and centrifuged in a Sorvall SS-34 rotor at 12000 rpm for 15 mins at 4°C. 
Supernatant was discarded and pellet was resuspended in SEM buffer and protein 
concentration was determined by the Bradford Assay (Bradford, 1976). Mitochondrial 
pellets were diluted in SEM buffer to a final concentration of 10 µg/µl, aliquoted, and 
stored at -80°C.  
 
3.4.9.2 Mitochondrial Preparation from SG at 18°C 
Isolation from yeast grown in SG at 18°C was performed essentially as described 
above with some variations.  For the primary culture, yeast colonies were picked and 
inoculated into SD medium and grown overnight at 30°C. Final SG cultures were 
grown at 30°C until OD600 of 1.0 and then transferred to 18°C until culture reached 
OD600 2.0 (generally 24 hours after temperature shift).  
 
3.4.10 Isolation of mitochondria from HEK 293T cells  
Human mitochondria were isolated from HEK293T cells as previously described 
(Lazarou et al., 2009; Reinhold et al., 2011). In brief, cells were harvested at 80-85% 
confluency in 1x PBS and 1 mM EDTA and homogenized in 0.1% BSA, 300 mM 
Trehalose, 10 mM HEPES-KOH pH 7.7, 10 mM KCl, 1 mM EDTA, 1 mM EDTA 
(Yamaguchi et al., 2007). Homogenized cells were subjected to centrifugation at 
11,000 x g at 4°C for 10 min and homogenization buffer without BSA was added to 
the mitochondria containing pellet. 
 
3.4.11 Labeling of precursor proteins with [35S] methionine 
For in vitro translation, ORFs of interest were amplified by PCR as described above. 
Amplified PCR products containing SP6 promoter sites were transcribed using the 
mMessage mMachine system. Each reaction mix contained 6 µl purified PRC product, 
1x SP6 reaction buffer, 1x NTP/CAP mixture and 2 µl Enzyme mix, and reactions 
were incubated for 2 hours at 37°C in a thermomixer. After 1 hour, 2 units of TURBO 
DNase were added and mixture was incubated for 15 min at 37°C. RNA sample was 
cleared by the Ambion Megaclear kit. Labeling of preproteins was performed using the 
Flexi® Rabbit Reticulocyte Lysate system (Promega). Each translation reaction 
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contained 20% RNA, 66% rabbit reticuloycte lysate, 70 mM potassium chloride, 1.4 
mM magnesium acetate, and 1.6 mM radioactive methionine. Samples were incubated 
in a thermomixer at 30°C for 90 min, followed by the addition of 150 mM sucrose and 
non-radiolabeled methionine to a final concentration of 8 mM. Lysates were aliquoted 
accordingly and stored at -80°C.  
 
3.4.12 Import and assembly of radiolabeled precursor protein 
3.4.12.1 Import into yeast isolated mitochondria 
Import of radiolabeled proteins into isolated yeast mitochondria were performed as 
described by Wiedemann et al., 2006.  Import reactions were performed in Standard 
Import Buffer and supplemented with 4 mM ATP, 4 mM NADH, 100 µg/mL creatine 
kinase, 5 mM creatine phosphate and 75 µg isolated mitochondria. For samples with 
dissipated membrane potentials, 1% (v/v) of 100 µM AVO was added whereas 1% 
(v/v) ethanol was added to other samples. Samples were incubated for 3 min at 25°C 
and import reactions were initiated with the addition of radiolabeled lysate (10-15% of 
total volume).  Imports were stopped at appropriate time points with the addition of 1 
µl 100 µM AVO and transferred to ice. Reactions were treated with 2.5 µg PK and 
incubated on ice for 15 min. 1 µl 0.2 M PMSF was added to halt PK activity and 
samples were centrifuged at 14,000 rpm for 10 min. Mitochondrial pellets were 
washed with 300 µl SEM buffer with 2 mM final concentration PMSF and centrifuged 
at 14,000 rpm for 10 min at 4°C. For SDS-PAGE analysis, pellets were resuspended in 
sample buffer and loaded on gels for electrophoresis. For BN-PAGE analysis, pellets 
were solubilized in Digitonin buffer (20 mM Tris pH 7.4, 50 mM NaCl, 0.5 mM 
EDTA, 10% (w/v) Glycerol, 1% (w/v) Digitonin, and 1 mM PMSF). After 
solubilization, samples were centrifuged at 14,000 rpm for 10 min at 4°C and the 
resulting supernatants were suspended in 10% (v/v) 1x BN Loading Dye, before 
loading on BN gels.  
 
3.4.12.2 Import into HEK293T isolated mitochondria 
Import of radiolabeled proteins into isolated human mitochondria was performed as 
described by Lazarou et al. (2009). For import of radiolabeled lysate into mitochondria 
from isolated mitochondria from HEK293T cells was performed essentially as 
described above with some notable changes. Import and assembly assays were 
incubated with freshly isolated mitochondria and not frozen mitochondria. Moreover, 
                                                                                      MATERIALS AND METHODS  
 42 
the import buffer (20 mM HEPES ⁄ KOH pH 7.4, 250 mM sucrose, 80 mM potassium 
acetate, 5 mm magnesium acetate, 10 mm sodium succinate and 5 mm methionine) 
was used.  Import reactions were performed at 37°C. 
 
3.4.13 Protein localization analysis 
To determine protein localization within isolated mitochondria, a protease protection 
assay was performed as previously described by Mick et al. (2007). Mitochondria, 
mitoplasts, or Triton X-100 lysed mitochondria were treated with various amounts of 
PK, in which then proteins were tested for localization to the mitochondrial outer 
membrane, mitochondrial inner membrane or matrix by SDS-PAGE and Western blot 
analysis. Mitochondria were resuspended in SEM buffer and treated with either 0, 20, 
or 100 µg PK. Swelling of isolated mitochondria was achieved by treatment in EM 
buffer (1 mM EDTA, 10 mM MOPS pH 7.2). The generated mitoplasts were treated 
with 0, 20 or 100 µg PK. Mitochondria lysed with 1% Triton X-100 were treated with 
0 or 100 µg PK. In all cases, PK treatment was allowed for 10 min on ice and followed 
by the addition of 0.2 M PMSF and incubated on ice for 10 min. All samples were 
centrifuged at 14,000 rpm at 4°C. The pellets of SEM-treated mitochondria and 
mitoplasts and the supernatant of Triton X-100 lysed mitochondria were resuspended 
in SDS-PAGE loading dye and analysed in by SDS-PAGE.    
 
3.4.14 Membrane association analysis  
Analysis was performed as previously described (Mick et al., 2007). To test protein 
membrane association, isolated mitochondria were suspended in 0.1 M carbonate 
buffer at pH 10.8 or 11.5, or alternatively lysed with 1% Triton X-100. All samples 
were incubated on ice and then subjected to ultracentrifugation at 45000 rpm for 45 
min at 4°C, in a TLA-55 rotor (Beckmann). Samples were TCA precipitated and 
subjected to SDS-PAGE analysis.  
 
3.4.15 In-gel activity assays  
Isolated mitochondria were solubilized in digitonin buffer and subjected to BN-PAGE 
gels, at which, coomassie containing-cathode buffer is exchanged, with 1x clear 
cathode buffer after 1 hour of electrophoresis at 200 mV. In-gel activity assays were 
performed on sliced gel stripes or whole gels, and incubated first in appropriate 
equilibration buffer (as indicated in Table 5) for 15 min followed by incubation in 
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staining buffer at RT or 30°C until the appearance of bands. Gel stripes were incubated 
in 50 ml equilibration buffer and 10 ml staining buffer, whereas whole gels were 
incubated in 100 ml equilibration and 50 ml staining buffer. A 4-10% gradient gel was 
used for the assessment of cytochrome c oxidase, complex I, and F1FOATPase 
monomer and dimeric forms. Alternatively, a 3-13% gradient gel was to analyze higher 
oligomers of F1FOATPase.  
 
Table 5. Composition of in-gel activity assay buffers. *Reduction of Cytochrome c 
(10 mg/ml) was achieved by resuspending 10 mg Cytochrome c in 1 ml 50 mM KPi 
pH 7.4 and 75 µg of Na-dithionite.  
 
 Equilibration buffer Staining Buffer 
Complex I 5 mM Tris / HCl pH 7.4 5 mM Tris /HCl pH 7.4 




50 mM KPi pH 7.4 50 mM KPi pH 7.4 
0.5 mg/ml DAB (3,3’ 
Diaminobenzidine) 
1 mg/ml of reduced Cytochrome 
c (bovine heart)* 
F1FOATPase 35 mM Tris, 220 mM 
Glycine pH 8.3  
35 mM Tris, 220 mM Glycine 
pH 8.3 
14 mM MgSO4 
0.2% Pb(NO3)2 
8 mM ATP 
 
3.4.16 Protein complex isolation by immunoprecipitation  
Isolation of yeast protein complexes was performed as previously described (Geissler 
et al., 2002).  In all cases, mitochondria isolated with tagged nuclear encoded proteins 
were solubilized in IP-Buffer (20 mM Tris/pH7.4, 50 mM NaCl, 0.5 mM EDTA, 10% 
(w/v) Glycerol, 1% (w/v) Digitonin, 1mM PMSF). After centrifugation at 14,000 rpm 
for 20 min, supernatants were incubated with appropriate column material in Mobicol 
columns for 1 hour at 4°C on an end-over-end shaker. Unbound proteins were 
removed by centrifugation at 100 x g for 1 min. Columns were then washed 10 times 
with 20x bead volume of Washing Buffer (20 mM Tris/pH7.4, 100 mM NaCl, 5 mM 
EDTA, 10% (w/v) Glycerol, 0.3% Digitonin, and 1 mM PMSF), and isolated proteins 
were eluted accordingly. For Large-scale isolation (1 mg mitochondria), solubilization 
of mitochondria was carried our in either Falcon tubes or 2 ml Eppendorf tubes. o 
indicates the appropriate experimental conditions for different isolations.  
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Table 6. Experimental conditions for various immunoprecipitation assays. 
Described buffer were used for native elutions. Alternatively, proteins can be eluted by 
SDS sample buffer. 
 
Type of tag Binding column material Elution Buffer 
ZZ 
(ProteinA)  






5 mM Desthio-Biotin, 20 mM Tris-HCl 
pH 7.4, 30 mM NaCl, 0.2 mM EDTA 
FLAG FLAG-agarose Flag peptide 20 mM Tris/pH7.4, 100 mM 
NaCl, 5 mM EDTA, 10%(w/v) Glycerol, 
0.3%(w/v) Digitonin, 1mM PMSF), 
 
3.4.17 Crosslining antibodies for co-immunoprecipitations 
To crosslink antibodies into sepharose columns for consequent use in co-
immunprecipitations, 100 µl of Protein A Sepharose (PAS) were added to a Mobicol 
column and centrifuged for 1000 rpm 5 min at RT. The sepharose was then washed 
twice with 500 µl 0.1 M KPi buffer pH 7.4. For each column 100 µl serum premixed 
with 300 µl with KPi buffer were added to the column followed by incubation on an 
end-over-end shaker of 1 hour at RT. Flow-through from the column was saved after a 
5 min centrifugation and the column was washed with 500 µl NaBorat and then 
incubated with NaBorat with 17.5 mg DMP for 30 min at RT.  Residual crosslinker 
was removed, first by centrifugation for 5 min at 1000 rpm, and then washing with 700 
µl 1 M Tris-HCl, pH 7.4. Mobicol columns were then incubated for 2 hours in 700 µl 1 
M Tris-HCl, pH 7.4 followed by centrifugation for 5 min at 1000 rpm. The column 
was stored at 4°C with 600 µl PBS with a final concentration of 2 mM sodium azide.  
 
3.4.18 Co-immunoprecipitation from isolated yeast mitochondria 
Antibodies against various yeast proteins were crosslinked to columns as described 
above. Isolated mitochondria were solubilized in digitonin buffer and applied to 
columns. Biochemical isolations were carried out using as for protein complex 
immunoprecipitations with the exception of eluting with 100 mM glycine pH 2.8.   
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3.4.19 Co-immunoprecipitation from HEK293T cells 
Isolation of protein complexes from human isolated mitochondria was performed 
either with beads coupled with antibodies raised against the F1FOATPase (α-
F1FOATPase) or against cytochrome c oxidase (α-COX) (Invitrogen). 
Immunoprecipitation of MINOS1-containing complexes were carried out using 
C1orf151/MINOS1 antibodies, cross-linked to Protein A/G Agarose (Pierce, 
Thermoscientific). In brief, 1 mg of isolated mitochondria from HEK293T cells was 
solubilized in 1 ml IP-buffer (20 mM Tris/pH7.4, 50 mM NaCl, 0.5 mM EDTA, 10% 
(w/v) Glycerol, 1% (w/v) Digitonin, 1 mM PMSF) for 20 min on ice. Insoluble 
material was removed by centrifugation (14.000 rpm, 20 min, 4°C). The remaining 
supernatent was incubated with the individual antibody coupled beads for 1 h at 4°C 
on an end-over-end shaker and centrifuged at 1000 rpm for 1 min at 4°C to remove 
unbound protein. The pelleted beads were transferred to a Mobicol column and beads 
were washed 10 times with W-buffer (20 mM Tris/pH 7.4, 50 mM NaCl, 0.5 mM 
EDTA, 10%(w/v) Glycerol, 0.3% (w/v) Digitonin, 1mM PMSF). Samples were finally 
eluted by SDS-PAGE sample buffer.    
 
3.5 Analytical Tools 
 
3.5.1 In silico analysis and multiple sequence alignments  
In silico analysis was performed using the Saccharomyces Genome Database (SGD). 
For multiple sequence alignments ClustalW 2.0.11 (Chenna et al., 2003) and 
geneious© (Biomatters, Limited) were used. Color coding was performed by  
Microsoft Word 2008. Black boxes were used to indicate identical residues in at least 
four species whereas gray boxes indicate similar amino acids, in accordance with 
Erdmann et al., 1991. Similarity rules used were (G=A=S. A=V, V=I=L=M, 
I=L=M=F=Y=W, K=R=H, D=E=Q=N, S=T=Q=N). Transmembrane predictions from 
primary amino acid sequences were performed by TMpred (Hofmann and Stoffel, 
1993).   
 
3.5.2 Mass spectrometry and data analysis   
For the identification of MINOS1 interacting proteins, SILAC (Ong et al., 2002) was 
used. Mitochondria from HEK29T cells grown in heavy or light isotopes (see Section) 
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were isolated and MINOS1 containing complexes were coimmunoprecipitated from 
the heavy-labeled culture, whereas a control antibody was used for light-labeled cells. 
The reverse (label-switch) experiment was performed by isolating MINOS1 specific 
complexes from light-labeled cells, whereas the control was used for heavy-labeled 
cells.  In all cases, elutions from coimmunoprecipitations were mixed before further 
analysis. Eluted proteins from either Mio10SF immunoprecipitations from isolated 
yeast mitochondria, or MINOS1 co-immunoprecipitations from HEK293T cells, were 
separated on 4-12% gradient SDS-PAGE gels (Invitrogen) and stained with Colloidal 
Coomassie Blue. SDS-PAGE gels were cut into 23 equal gel slices and proteins were 
in-gel digested with trypsin (Promega) as described previously (Shevchenko et al., 
2006). The resulting tryptic peptides from each gel slice were analyzed by nanoflow 
HPLC (Agilent 1100, Agilent Technologies) coupled to nanoelectrospray LTQ-
Orbitrap XL mass spectrometer (Thermo Fischer Scientific). For yeast Mio10SF 
immunoprecipitations, the raw MS files were searched and analyzed with Mascot 
(Mascot Deamon version 2.2.2, Matrix Science) and Scaffold 3 (Proteome Software) 
using the S. cerevisiae NCBI non-redundant protein database. The normalized fold 
change ratios were then calculated in Scaffold using the spectral count approach (Liu 
et al., 2004). For SILAC analysis of MINOS1 immunoprecipitations, the raw MS files 
were analyzed by MaxQuant (Cox and Mann, 2008) and Mascot using IPI Human 
protein database (version 3.82). MaxQuant was used to analyze and visualize results  
with R as described (Nikolov et al., 2011). Mass spectrometric analysis performed by 
Monika Raabe and Miroslav Nikolov (AG Urlaub, MPI-bpc, Göttingen).  
 
3.5.3 Fluorescence microscopy 
3.5.3.1 Subcellular localization by immunofluorescence 
Immunofluorescence was performed with African green monkey (Cercopithecus 
aethiops) kidney epithelial cells (Vero), as previously described (Wurm et al., 2010). 
In brief, cells were grown on cover slips under standard conditions and then fixed in 
8% paraformaldehyde  (PFA) and permeabilized in 0.5 % (v/v) Triton X-100. Treated 
cells were then incubated for 1 hour with C1orf151/MINOS1-antibody and the 
mitochondrial marker Cyclophilin D-antibody at a dilution of 1:400. Cells were then 
washed cells and incubated for 1 hour with Oregon Green 488 conjugated goat anti-
mouse IgGs (1:1000; Molecular Probes) and KK114 conjugated goat anti-rabbit IgGs 
(1:200) (Kolmakov et al., 2010). Cells were again washed and stained with DAPI 
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staining for 5 min before embedding in mounting medium. Fluorescence microscopy 
was performed with a beam scanning confocal microscope (TCS SP5, Leica 
Microsystems CMS GmbH, Wetzlar Germany) equipped with 1.4 NA oil immersion 
lenses (63 x; HCX PL APO, Leica). Microscopy was performed by Daniel Jans (AG 
Jakobs, MPI-bpc).  
 
3.5.3.2 Morphology analysis by Life-cell imaging fluorescence    
To visualize mitochondrial networks in yeast, cells were first transformed with a 
pVT100U-mitoGFP vector (Westermann and Neupert, 2000). Selected colonies were 
first verified for GFP expression and then cultured overnight in selective SGG-
Medium (0.5g/l yeast extract, 6.7g/l yeast nitrogen base, 0.77g/l CSM-URA dropout 
mix, 30ml/l Glycerol, 1g/l Glucose). Cultured cells were directly used for fluorescence 
microscopy with no further manipulation. Images were collected by a DeltaVision 
microscope (Olympus IX71, Applied Precision) equipped with a 100x objective and a 
FITC filter and deconvolved with Softworx  (Applied Precision) version 3.5.1. 10–15 
Z-section images were taken for each image at 0.5µm intervals. Microscopy was 
performed by Daniel Jans (AG Jakobs, MPI-bpc).  
 
 
3.5.4 Electron microscopy 
For analysis of mitochondrial morphology of various mutants, electron microscopy, in 
which sample specific were vitrified by high pressure freezing or chemical fixed by 
potassium permanganate before examination.  
 
3.5.4.1 High-pressure-freezing 
Yeast cells were grown in liquid YP Lactate medium (10 g/l yeast extract, 20 g/l 
peptone from casein, 23 ml/l L(+)-lactic acid solution (85%), 0.02 g/l uracil, 0.02 g/l 
adenine sulfate) at 30°C. Cultures were allowed to allowed to reach a logarithmic 
growth phase (OD600 approximately 2.0) at which point they are harvested.  Cells were 
transferred onto 150µm aluminum planchette and a Leica HPM100 high pressure 
freezer (Leica Microsystems, Wetzlar, Germany) was used to vitrify samples followed 
by embedding in 0.5% glutharaldehyde, 0.1% uranylacetate and 5% H2O (Giddings, 
2003) using a freeze substitution unit (Leica EM AFS, Leica Microsystems). Samples 
were warmed to room temperature and the pellet was removed from the planchette 
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followed by embedding in expoxid resin (Agar 100, Plano) and polymerization at 
+80°C for 48 hours. Thin sections (60nm) were counterstained with 1% uranylacetate 
in methanol and lead citrate and prior to examination with a Philips CM 120 BioTwin 
transmission electron microscope (Philips Inc., Eindhoven, Netherlands). Microscopy 
and analysis were performed in collaboration with Dietmar Riedel (Mpi-bpc, 
Göttingen)  
 
3.5.4.2 Chemical fixation 
Chemical fixation of sample specimens with potassium permanganate was essentially 
performed as described by Erdmann et al., 1989. Yeast cells were first cultured for 12h 
at 18°C in liquid SGG medium (0.5g/l yeast extract, 6.7g/l yeast nitrogen base, 0.77g/l 
CSM dropout mix, 30ml/l Glycerol, 1g/l Glucose).  Cells were then fixed in 1.5% 
potassium permanganate at room temperature for 2 min, and consequentially treated 
with 1% uranyl acetate for 2 hours. Fixed cells were then dehydrated in a graded 
ethanol series and embedded in Epon 812 resin. Ultrathin sections were mounted on 
Formvar-coated single hole grids, and examination was performed in a Philips EM 300 
(Phillips Inc., Eindhoven, Netherlands). Microscopy and analysis were performed in 
collaboration with Wolfgang Schliebs (Ruhr Universität Bochum, Bochum).  
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4. RESULTS  
 
 
4.1 Identification of a putative F1FOATPase dimerization factor in 
higher eukaryotes (H. sapiens)  
 
4.1.1 in silico analysis: identification of Mio10 and MINOS1  
Various structural subunits of the F1FOATPase were described to be involved in 
dimerization in various species ranging from simple eukaryotes to mammals 
(Soubannier et al., 2002; Fronzes et al., 2003). In addition, subunits Atp18, Atp19, 
Atp20, and Atp21 have been described to play a major role in inducing dimerization in 
yeast by promoting F1FOATPase homo-monomeric interactions (Arnold et al., 1997, 
1998; Soubannier et al., 2002; Paumard et al., 2002a; Wagner et al., 2009, 2010). The 
presence of these small FO associated dimerization factors does not seem to be 
conserved in higher eukaryotes. Whereas homologs of subunits Atp18 and Atp19 are 
not found in mammals, subunits Atp20 (subunit g) and Atp21 (subunit e) are present 
(Kucharczyk et al., 2009). However, a role of these subunits in dimerization has not 
been demonstrated. Thus, information is still lacking on what mediates F1FOATPase 
dimer-interface interactions in higher eukaryotes.  
 
An in silico analysis was performed in order to identify novel F1FOATPase 
dimerization factors in higher eukaryotes (Figure 9). The bioinformatics analysis was 
based on searching for ORFs with protein products of similar characteristics to 
dimerization factors already characterized in yeast (Atp18, Atp19, Atp20, and Atp21). 
Most importantly, the protein should have a significant human homolog, defined by a 
low Expect (E) value from sequence homology searches. As illustrated in Figure 9, 
mitochondrial localized proteins were filtered through various parameters using the 
SGD database. Potential ORFs of interest would code for an uncharacterized protein 
with at least one transmembrane domain and a size equal to or smaller than 12 kDa. 
Similar to Atp20 and Atp21, the protein would contain a GxxxG motif in its 
transmembrane domain. Two ORFs, YJR085C and YCL057c-A complied with these 
conditions, both having potential human homologs based on E-values, of 3x10-8 and 
6x10-6 respectively*. In this study, YCL057c-A (termed Mio10), as well as its 
potential human homolog C1orf151 (termed MINOS1), were analyzed.  
 







Figure 9. Identification of Mio10 and MINOS1 by in silico analysis. (A) The 
Saccharomyces Genome Database (SGD) was screened for all mitochondrial proteins with a 
size <12 kDa and uncharacterized molecular function, and consequently for membrane 
proteins that have significant human homology (based on E values) by BLAST search. (B) 
Sequences of the proteins with significant human homologs. Regions with GxxxG motifs are 
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4.1.2 Mio10 and MINOS1 sequence analysis and alignments  
Analysis of the primary amino acid sequences of Mio10 and MINOS1 indicated that 
both ORFs encode small proteins of 97 and 78 amino acids, of approximately 10 and 8 
kDa in size, respectively (Figure 10). Sequence analysis indicated that neither has a 
predicted presequence. In addition, Mio10 and MINOS1 are predicted to contain two 










Figure 10. Molecular organization of selected proteins. (A) Mio10, and (B) MINOS1. 
Black boxes indicate predicted transmembrane (TM) domains. No predicted mitochondrial 
presequence predicted.  N, amino-terminus; C, carboxyl-terminus.  
 
 
Interestingly, Mio10 and MINOS1 appear to be highly conserved across all 
examined species. Figure 11 depicts a multiple sequence alignment of Mio10 in 
various yeast species.  The N-termini and C-termini are weakly conserved across 
analyzed yeast species. Moreover, it appears that protein sequences encoding the two 
transmembrane domains are highly conserved with the two GxxxG motifs unaltered in 
all examined yeast species. The primary amino acid sequence of MINOS1 from 
various species representing vertebrates and invertebrates were also analyzed in a 
multiple sequence alignment (Figure 12). The N- and C-termini, like those of Mio10, 
appear to be variable across various species, whereas sequences encoding the two 
transmembrane domains are highly conserved, with the GxxxG motifs unaltered. This 
variation of N- and C-termini may indicate the importance of the transmembrane 
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Figure 11. Alignment of Mio10 yeast homologs. Multiple sequence alignment performed by 
ClustalW 2.0.11. Black boxes indicate identical residues in at least four species; gray boxes 
indicate similar amino acids according to Erdmann et al., 1991.  Sc, S. cerevisiae; Zr, Z.rouxii; 
Vp, V. polyspora; Ct, C. tropicalis; Ca, C. albicans; Dh, D. hansenii; Pp, P. pastoris; Yl, Y. 
lipolytica; Cg, C. globosum; Ag, A.gossypii; Lt, L. thermotolerans; Kl, K. lactis; Nc, N. crassa; 
Mo, M. oryzae; Pa, P. anserina; Tr, T. reesei; Ss, S. sclerotiorum; Tt, T. tonsurans; Sp, S. 









  Sc Mio10  MSEQAQTQQPAKSTPSKDSNKNGSSVSTILDTKWDIVLSNMLVKTAMGFGVGVFTSVLFF  60 
  Zr Mio10  MAEQQQQAQLQVTAPNK----------SILNDKWDVVLSNLLVKSGLGFGVGVVASVLIF  50  
  Vp Mio10  MSQQSQELQIT-SAPTR----------SILNDKWDVVLSNFLVKTSLGFGAGVLASVILF  49 
  Ct Mio10  MSTETK-QELLPTPP-------ATASQNLLNDKWDVVLSNALIKTGLGFGGGVLASILFF  52 
  Ca Mio10  MSTEIKPQELVPS----------TASQNLLNDKWDVVLSNTLIKTGLGFGGGVLASILFF  50 
  Dh Mio10  MVNTNKYFRTMSTEQKV-----AAPSQSLLNDKWDVVLSNTLIKTGLGFGGGVLASILLF  55 
  Pp Mio10  MSESKQLSQPVSS--------------TLLNDKWDVVLANTVVKTGLGFGGGVLLSVLFF  46 
  Yl Mio10  MGDTVATNLQLLT-------------------QWDVVISNTLVKTGLGFGAGVLASVLFF  41 
  Cg Mio10  MSNKEETKAKTVD---------YTPVRSILNDKWDVVLSNMIVKMGLGFGVGVVTSVLFF  51 
  Ag Mio10  MSGQLEVSAPSRS---------------ILNDKWDVVLSNLVVKTGLGFGAGVFASVLFF  45 
  Lt Mio10  MSEQLKVSPTSRS---------------LLNDKWDVVLSNLVVKTGLGFGAGVVASVLLF  45 
  Kl Mio10  MSEQVQTTKAVPS---------------ILDKRWDVVLSNVVAKTALGAGVGIVASVLFF  45 
  Nc Mio10  MSDSTSSPVAAAPSTAM----TRPVSEALLNEKWDRCLSNLLIKSTLGLGFGVVFSVLIF  56 
  Mo Mio10  MSET--APPTRSP--AF----ARPVSEALLNEKWDHCLSNLLIKSTLGLGFGVVFSVLVF  52 
  Pa Mio10  MADTAPATTTSPTSRAV----SRPVSEALLNEKWDRCFSNLIIKSSLGLGFGVVFSVLLF  56 
  Tr Mio10  MSET--AAPRSPS--AI----SRPVSEALLNEKWDRCLSNLLVKSTLGLGFGVVFSVLLF  52 
  Ss Mio10  MPET-SISPPAVTRP------SKPVSEALLNEKWDHCLSSLLIRSSVGLGFGVVASVLIF  53 
  Tt Mio10  MADS-AESTQSVPVPRA----SKPVSETLLNEKWDRAISSLLIRSSVGLGFGVIFSILLF  55 
  Sp Mio10  MSTSQSSEQ-------------------TLNYQWDVCLSNMVVQSGIGLGAGIVSSVLFF  41 
  Bd Mio10  MESQTAESKTIPS-------------EELLARKWDKCLSNFVIKSGLGLTVGVSLSFLLF  47 
             
 
  Sc Mio10  KRRAFPVWLGIGFGVGRGYAEGDAIFR-SSAG----LRSSKV------- 97 
  Zr Mio10  KRRAFPVWLGIGFGLGRGYAEGDAIFR-SAAG----LRTSKA------- 87 
  Vp Mio10  KRRAFPVWLGIGFGIGRGYSEGDAIFR-SAAG----LRKSTV------- 86 
  Ct Mio10  KRRAFPVWLGVGFGLGRGYSEGDAIFR-SNHG----LRTVKV------- 89 
  Ca Mio10  KRRAFPVWLGVGFGLGRGYAEGDAIFR-SNHG----LRTVKA------- 87 
  Dh Mio10  KRRSFPVWLGVGFGLGRGYSEGDAIFR-SNHG----LRTVKA------- 92 
  Pp Mio10  KRRAFPVWLGIGFGLGRGYSEGDAIFR-SPAG----LRDVKA------- 83 
  Yl Mio10  KRRTFPVWLGIGFGAGRGVAEGDVIFRQSDAG----VRSVRA------- 79 
  Cg Mio10  KRRSFPVWLGVGFGAGRGYSEGDAIFR-STAG----LRSVKV------- 88 
  Ag Mio10  KRRAFPVWLGVGFGLGRGYAEGDAIFR-SHAG----LRAVRA------- 82 
  Lt Mio10  KRRAFPVWIGVGFGLGRGYAEGDAIFR-SSAG----LRTVKA------- 82 
  Kl Mio10  KRRAFPVWVGVGFGLGRGYAEGDAIFR-TNAG----LRKVNA------- 82 
  Nc Mio10  KRRAWPAFVGVGFGAGRAYEECNTSLKQAAR----EIRAQA-------- 93 
  Mo Mio10  KRRAWPAFVGAGFGAGRAYEECNYNLKQTAR----EIRRQA-------- 89 
  Pa Mio10  KRRAWPAFVGVGFGAGRAYEECNSSLKQAAK----EIRKQA-------- 93 
  Tr Mio10  KRRAWPAYLGAGFGAGRAYEECNFNLKQAAR----DLKKPSV------- 90 
  Ss Mio10  KRRAWPAFVGVGFGAGRAYEECNSSFRRVGK---DGIRVQRP------- 92 
  Tt Mio10  KRRAWPAWVGLGFGAGRAWEEADASFRRGDQPWSQNLRFPRSS------ 98 
  Sp Mio10  RRAAWPVWGGLGFGLGKSYADSNARLRTFHAI----PKQLPASSTQKKD 86 
  Bd Mio10  RRRGWPIGLATGFGAGMAYSQCSQSLAASTLLP---ASTPKQ------- 86 
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Figure 12. Alignment of MINOS1 homologs. Multiple sequences preformed by ClustalW 
2.0.11. (A) Vertebrates (B) Invertebrates. Black boxes indicate identical residues in at least 
four species; gray boxes indicate similar amino acids according to Erdmann et al., 1991. Hs, 
H. sapiens; Pt, P. troglodytes; Mcm, M. mulatta; Nl, N. leucogenys; Mm, M. musculus; Rn, R. 
norvegicus; Ec, E.caballus; Bt, B. taurus; Fc, F. catus; Cl, C. lupus familiaris; Gg, G. gallus; 
Dr,D. rerio; Xl, X. laevis; Vp, V. pacos; Pc, P. capensis; Tb, T. belangeri; Cp, C.porcellus; 
Md, M. domestica; Oc, O. cuniculus; Op, O. princeps; Dm, D. melanogaster; Am, A. 
mellifera; Cel, C. elegans; Tb, T. castaneum; At, A. thaliana; Gm, G. max; Os, O. sativa; Zm, 
Z. mays. For Dm: a, b, and c indicate different isoforms. For Cel, MINOS1 termed MIO-10 in 







Hs MINOS1 MSESELGRKWDRCLADAVVKIGTGFGLGIVFSLTFFKRRMWPLAFGSGMGLGMAYSNCQHDFQAPYLLHGKYVKEQEQ-  78  
 Pt MINOS1 MSESELGRKWDRCLADAVVKIGTGFGLGIVFSLTFFKRRMWPLAFGSGMGLGMAYSNCQHDFQAPYLLHGKYVKEGAH-  78 
Mcm MINOS1 MSESELGRKWDRCLADAVVKIGTGFGLGIVFSLTFFKRRMWPLAFGSGMGLGMAYSNCQHDFQAPYLLHGKYVKEQEQ-  78 
 Nl MINOS1 MSESELGRKWDRCLADAVVKIGTGFGLGIVFSLTFFKRRMWPLAFGSGMGLGMAYSNCQHDFQAPYLLHGKYVKEQEQ-  78 
 Mm MINOS1 MSESELGRKWDRCMADTVVKLGTGFGLGIVFSLTFFKRRMWPLAFGSGVGLGMAYSNCQHDFQAPYLLHGKYVKEQ---  76 
 Rn MINOS1 MSESEPGRKWDRCMADALVKLGTGFGLGMVFSLTFFKRRKWPLAFGSGVGLGMAYSNCQHDFQAPYLLHGKYVKEQ---  76 
 Ec MINOS1 MSDSELGRKWDRCLADAVVKIGTGFGLGLVFSLTFFKRRMWPLAFGSGMGLGMAYSNCQHDFQAPYLLHGKYVKEPEQ-  78  
 Bt MINOS1 MSESELGRKWDRCLADAVVKIGTGFGLGLVFSLTLFKRRMWPLAFGSGMGFGMAYSNCQHDFQAPYLLHGKYVK-----  74 
 Fc MINOS1 MSDSELGRKWDRCMADAVL-IGTGFGLGLVFSLTFFKRRMWPLAFGSGMGLGMAYSNCQHDFQAPYLLHGKYVKEQEQ-  78 
 Cl MINOS1 MSDSELGRKWDRCMADAVVKIGTGFGLGLVFSLTFFKRRMWPLAFGSGMGLGMAYSNCQHDFQAPYLLHGKYVKEQEQ-  77 
 Gg MINOS1 -SEGELGRKWDRCLADSAVKLGAGFGLGIVFSVIFFKRKTWPIAFGSGMGLGMAYSNCQHDFQSPYLLHGKFVK-----  73 
 Dr Minos1 MSEKALGQKWDRCLADCAIKVGTGLGLGIVFSVVFFKRRTSPIALGTGIGLGMAYSNCQNDLRSHYQLHRSAAKEQ---  76 
 Xl minos1 MSEKELGRKWDRCLADSAVKFGAGLGLGIVFSVIFFKRKTWPIAFSSGIGLGMAYSNCQNDFQSPYLLHGKFVKEQ---  76 
 Vp MINOS1 MSDSELGRKWDRCLADAVVKIGTGFGLGLVFSLTFFKRKTWPLAFGSGMGLGMAYSNCQHDFQAPYLLHGKYVKEQEP-  78 
 Pc MINOS1 MSDSELGRKWDRCLADAVVKIGTGFGLGIVFSLTFFKRRMWPLAFGSGMGLGMAYSNCQHDFQAPYLLHGKYVREQ---  76 
 Tb MINOS1 MSESELGQKWDRCMADAVVKIGTGFGLGIVFSLTFFKRRMWPLAFGSGMGLGMAYSNCQHDFQAPYLLHGKYVK-----  74 
 Cp MINOS1 MSESDLGRKWDRCLADAVVKIGTGFGLGVVFSLTFFKRRMWPLAFGSGMGLGMAYSNCQHDFQSPYLLHGKYVK-----  74 
 Md MINOS1 MSDSDLGRKWDRCLADTVVKLGTGFGLGIVFSLTFFKRRMWPLAFGSGMGLGMAYSNCQHDFQAPYLLHGKYVKVQEQ-  78 
 Oc MINOS1 MSESDIGRKWDRCMADTVVKIGTGFGLGVVFSLTFFKRKSWPLAFGSGMGLGMAYSNCQHDFQAPYLLHGKYVKEQEQ-  78 





 Dm Minos1a   MSTTP--------EDRLREN----------INRCLSDSLVKGVGGLVIGSVVTLLFFRRR  42 
 Dm Minos1b   MTSRDN-----IFEEKICNR----------LDHCVSDVLIKGCGGVIIGSAVSFLILKRR  45 
 Dm Minos1c   MSHEPQ-----KPAKSAVKEPPVVSEETRTTDKCLADFCLKGGSGLIIGSAVTLFFTRPQ  55 
 Am Minos1    MAT--------WVEDEIGRK----------WDRCFTDAIFKFGGGILLGGVFSLFFFKRR  42 
Cel MIO-10    MAPGASAPAASRSEDEVGQK----------IDRCFADSLLKVTGGVAIGIVASVAFFKSR  50 
 Tc Minos1    MASPV------YVEEELGRK----------WDRCFSDALLKFGGGVVLGSVFSLLFFKRR  44 
 
 Dm Minos1a   IWPVWLGTGFGVGVAYRGCEKELNDVKFGQRK-----------------------  74 
 Dm Minos1b   AWPVWLGAGFGMGIAYRTCEKDLNSLK----------------------------  72 
 Dm Minos1c   TYPIWLGLGVGMGVAYDCCQARWNQQ-----------------------------  81 
 Am Minos1    KWPIITGAGFGLGMAYANCQEDLNSAIRQQQKRDCTKVDEGIKNS----------  87 
Cel MIO-10    SWPIWFGSGVGLGTGWSNCRHDFASPYVLHGKRVPAGQDSQGKPAYNIITEQHKQ  105 
 Tc Minos1    RWPVVMGGGFGIGMAYSNCERDLNATIR----------DRSL-------------  76 
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4.2 Topological analysis of Mio10 and MINOS1 
 
F1FOATPase dimerization factors are membrane proteins that interact with the inner 
membrane embedded FO portion of F1FOATPase (Wagner et al., 2010). In order to 
investigate a possible role of Mio10 and MINOS1 in F1FOATPase dimerization, 
their association with the inner membrane was investigated. To this end, antibodies 
that specifically recognize Mio10 and MINOS1 were required. Once these antibodies 
were verified, mitochondrial sublocalization and membrane association assays were 
performed.  
 
4.2.1 Antibody generation and specificity  
To analyze endogenous MINOS1 protein signals a commercially purchased antibody 
against MINOS1 was used. MINOS1 antibody specificity was tested, in which a 
protein extract from either whole-cell lysate or from isolated mitochondria were 
analyzed by Western blotting (Figure 13A). In both cases, the MINOS1 antibody 
recognizes a protein of approximately 10 kDa in size. The antibody non-specifically 
recognizes proteins of 14 and 60 kDa in size; these proteins however are not present in 
the mitochondrial protein extract indicating that the only the 10 kDa protein is 
imported and incorporated into mitochondria.  
 
Figure 13. Antibody specificity test. (A) Western-blot analysis of HEK293T whole-cell 
extract (lysate) and HEK293T isolated mitochondria using MINOS1 specific antibodies.  (B) 
Western-blot analysis of whole-cell protein extracts from wildtype and mio10∆ yeast culture 
using Mio10 specific antibodies. In (A) and (B), 10 µg protein was loaded on each lane. * 
indicates non-specific antibody cross-reaction.  
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In contrast, an antibody was generated to analyze endogenous Mio10 protein 
signals by Western blot analysis (Figure 13B). This has been achieved by using a 
chemically synthesized peptide (EGDAIFRSSAGLRSSKV) corresponding to the C-
terminal of the Mio10 protein. Antibody specificity evaluation was performed by 
analyzing whole-cell proteins extracts from wildtype and mio10∆ strains. Western blot 
analysis indicates that the raised antibody specifically recognizes a protein product 
slightly larger than 10 kDa. The antibody, however, also recognizes two nonspecific 
protein products of approximately 22 and 60 kDa in size. It should be noted that the 
antibodies against Mio10 and MINOS1 did not recognize their respective epitopes on 
Blue native PAGE (BN-PAGE), which can be used to characterize large complexes in 
their native state (Nijtmans et al., 2002). For immunodetection purposes, the 
antibodies were primarily used with SDS-PAGE. 
 
4.2.2 Topological analysis of Mio10    
To assess whether Mio10 was a membrane protein, a carbonate extraction analysis was 
performed on isolated wildtype mitochondria (Figure 14A). Upon treatment with 
carbonate buffer, followed by high-speed centrifugation, Mio10 was carbonate 
resistant and remained in the membrane pellet, similar to mitochondrial integral 
membrane proteins Tom70 and Tim21. On the other hand, the peripherally membrane 
associated protein Tim44 was released into the supernatant. This result indicates that 
Mio10 behaves like an integral membrane protein. As a control, treatment of 
mitochondria with Triton X-100 (TX-100) released all proteins into the supernatant.  
 
In addition, the sublocalization of Mio10 was assessed by a protease protection 
assay, in which wildtype mitochondria were treated with various concentrations of 
Proteinase K (Figure 14B). Tom70, which is localized at the mitochondrial outer 
membrane, was degraded, whereas Mio10 was protected against protease degradation. 
Upon osmotic disruption of the outer membrane and thus generation of mitoplasts and 
exposing protein contents and protein domains associated with the IMS, Mio10 was 
rendered accessible to protease degradation. In contrast, matrix proteins (Tim44 
control) were unaffected. As the antibody is specific the C-terminus of Mio10, the 
partial loss of antibody signal by Western blot analysis indicates that the affected C-
terminus of Mio10 is located in the IMS. This is supported by the observation that the 
pattern of Mio10 PK degradation pattern resembles that of Tim21, an inner membrane 
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protein, in which PK treatments leads to partial degradation of its IMS exposed C-
terminus (Chacinska et al., 2005). These results combined with membrane association 
results indicate that Mio10 is an integral mitochondrial inner membrane protein with 




Figure 14. Mio10 is a mitochondrial IMS protein. (A) Membrane association assay. 
mitochondria were suspended in carbonate buffer, or alternatively lysed with 1% Triton X-
100. All samples were incubated on ice and then subjected to ultracentrifugation and TCA 
precipitation followed by SDS-PAGE and Western blot analysis. B) Protease protection assay; 
mitochondria, and mitoplasts were treated with various amounts of PK. The pellets of SEM-
treated mitochondria and mitoplasts were resuspended in protein loading dye and analyzed by 




4.2.3 Subcellular localization of MINOS1 by immunofluorescence  
Sequence analysis of the MINOS1 ORF (C1orf151) indicated predicted a 
mitochondrial localization based on large-scale mitochondrial genetic screen 
(Baughman et al., 2009). To verify this, immunofluorescence microscopy using 
MINOS1 specific antibodies was performed (Figure 15). Antibodies against MINOS1 
and the mitochondrial marker Cyclophilin D were applied to monkey epithelial kidney 
cells, VERO. Image analysis revealed co-localization of MINOS1 and Cyclophilin D 
antibody signals, supporting the notion that MINOS1 is a mitochondrial protein. 
Moreover, cells were stained with the nuclear marker DAPI, indicating that both 












Figure 15.  MINOS1 is a mitochondrial localized protein. Immunofluorescence analysis of 
MINOS1 localization. VERO cells were fixed in 8% paraformaldehyde  (PFA) and 
permeabilized in 0.5 % (v/v) Triton X-100. Treated cells were then incubated for 1 hour with 
MINOS1-antibody and the mitochondrial marker Cyclophilin D-antibody. Cells were then 
washed cells and incubated with Oregon Green 488 conjugated IgGs and KK114 conjugated 
goat IgGs. Cells were then stained with DAPI staining before performing fluorescence 






4.2.4 Topological analysis of MINOS1  
To test MINOS1 membrane association, a carbonate extraction analysis was performed 
on mitochondria isolated from HEK293T cells, in which cultured cells were treated 
with carbonate buffer pH 10.8 or 11.5 (Figure 16A). In all cases, MINOS1 appeared 
carbonate resistant and remained in the membrane pellet similar to mitochondrial 
integral membrane proteins TOM70 and TIM23. On the other hand, the matrix protein, 
TACO1, was released into the supernatant. The results thus indicate that MINOS1 is 










Figure 16. MINOS1 is a mitochondrial IMS protein. (A) Protease protection assay; 
mitochondria, mitoplasts, or Triton X-100 lysed mitochondria were treated with various 
amounts of PK. The pellets of SEM-treated mitochondria and mitoplasts and the supernatant of 
Triton X-100 lysed mitochondria were resuspended in protein loading dye and analyzed in by 
SDS-PAGE.   PK, Proteinase K; TX-100, TritonX-100. (B) Membrane association assay. 
Mitochondria were suspended in carbonate buffer, or alternatively lysed with 1% Triton X-
100. All samples were incubated on ice and then subjected to ultracentrifugation and TCA 
precipitation followed by SDS-PAGE and Western blot analysis. T, total; P, pellet; S, 
supernatant. * indicates non-specific antibody cross-reaction. 
 
To analyze MINOS1 sublocalization, isolated mitochondria from HEK293T 
cells and mitoplasts were treated with various concentrations of PK in a protease 
protection assay (Figure 16B). When mitochondria were treated with various 
concentrations of PK, MINOS1 appeared to be protected against protease degradation. 
TOM70, which is localized at the mitochondrial outer membrane, was degraded by 
PK. Moreover, when mitoplasts were treated with PK, MINOS1 was accessible to 
protease treatment. The matrix protein TACO1 was unaffected. MINOS1 accessibility 
was similar to TIM23, an inner membrane protein with its C-terminus exposed to the 
IMS, supporting the notion that MINOS1 has a similar topology. As a control, all 
proteins were degraded after treatment with T-X100. The MINOS1 pattern of PK 
degradation parallels that of the one observed for Mio10, and thus it was concluded 
that MINOS1 and Mio10 have a similar topology in the mitochondrial inner 
membrane. These results combined with membrane association assay results indicate 
that MINOS1 is an integral mitochondrial inner membrane protein with its N- and C-
termini exposed to IMS.  Thus based on results from the protease protection assay and 
membrane association assay, it is deduced that the MINOS1, together with its yeast 
homolog Mio10, are mitochondrial inner membrane proteins with both of their termini 
exposed to the IMS (Figure 17). 
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Figure 17. Topology of Mio10 and MINOS1. Subfractionation and membrane association 
analysis indicate that Mio10 is an integral mitochondrial inner membrane protein with its N 
and C termini exposed to the IMS.  N, Amino-terminus; C, Carboxyl-terminus; TM, 




4.3 Analysis of Mio10 and MINOS1 association with the F1FOATPase 
 
In order to investigate the roles of Mio10 and MINOS1 with respect to F1FOATPase 
dimerization, Mio10 and MINOS1 containing complexes were first investigated by 
BN-PAGE. This technique allows the separation of large proteins complexes without 
their dissociation and has been useful in the analysis of various F1FOATPase 
dimerization factors  (Arnold et al., 1999; Nijtmans et al., 2002; Wagner et al., 2009). 
Because of the Mio10 and MINOS1 antibodies limitations on BN-PAGE, in vitro 
synthesized radiolabeled precursors of the proteins were used. Import and assembly 
were performed. In addition, interactions of Mio10 and MINOS1 with F1FOATPase 
were investigated by biochemical isolations from strains containing tagged 
F1FOATPase components.  
 
4.3.1 in vitro import of Mio10 and analysis by SDS-PAGE   
A 35S-labeled Mio10 precursor was synthesized in vitro and imported into energized or 
membrane potential depleted wildtype mitochondria in the presence or absence of PK 
(Figure 18). Mio10 is imported in a non-membrane potential manner. Furthermore, 
Mio10 appears to be protected against PK treatment. As a control [35S]Su9-DHFR was 
imported. This preprotein is composed of the N-terminal 69 residues of the 
F1FOATPase subunit 9 (Su9) precursor of N.crassa, fused with the mouse 
dihydrofolate reductase (DHFR) (Pfanner et al., 1987). In contrast to Mio10 import, 
Su9-DHFR import indicated both membrane potential dependency and PK sensitivity.  






Figure 18. Import of Mio10 into mitochondria is membrane potential independent. (A) 
Schematic diagram representing in vitro import of radiolabeled lysate in mitochondria. (B) 
Radiolabeled Mio10 and Su9-DHFR were imported into isolated mitochondria in the presence 
or absence of a membrane potential for the indicated times. Samples were split and left 
untreated or treated with proteinase K (PK) and analyzed by Tricine-SDS–PAGE and digital 
autoradiography. As control, lysate containing Mio10 precursor or Su9-DHFR were applied 
(Lys.); p, precursor; m, mature protein.  
 
 
4.3.2 Mio10 and MINOS1 assembly analysis by BN-PAGE  
Radiolabeled Mio10 and MINOS1 labeled precursors were synthesized in vitro and 
imported into energized or membrane potential depleted wildtype yeast mitochondria, 
which were then solubilized in mild digitonin buffer and analyzed by BN-PAGE 
(Figure 19A). Mio10 assembles in a time and membrane potential dependent manner 
into complexes of various size, ranging from high molecular components (>669 kDa) 
to smaller complexes (approximately 160 kDa). Interestingly, MINOS1 imports and 
assembles in yeast mitochondria. Moreover Mio10 and MINOS1 labeled precursors 
were imported and assembled in HEK293T isolated mitochondria (Figure 19B). Mio10 
appears to assemble in human mitochondria, at which Mio10 and also MINOS1, as in 
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Figure 19. Mio10 and MINOS1 assemble into high molecular sized mitochondrial 
complexes. Radiolabeled Mio10 precursor was imported into isolated wildtype mitochondria 
in the presence or absence of membrane potential for the indicated times. Radiolabeled Atp21, 
Atp20 and Cox13 were imported in parallel. All samples were treated with proteinase K, 
solubilized in digitonin buffer, and subjected to BN-PAGE (4-10% gradient gel). Protein 
complexes signals were detected by digital autoradiography. V2, V, III2IV, and III2IV2 indicate 




4.3.3 Comparison of Mio10 complexes assembly with the F1FOATPase 
In order to analyze the biogenesis of Mio10-containing complexes in mitochondria a 
radiolabeled precursor of Mio10 was imported into wildtype isolated mitochondria and 
then analyzed by BN-PAGE (Figure 20). In comparison, Cox13, a structural subunit of 
the cytochrome c oxidase, was assembled in wildtype mitochondria (Tsukihara et al., 
1996). Indeed, Mio10 assembles into complexes larger than respiratory chain 
supercomplexes, III2IV and III2IV2. When Atp20 assembly was preformed in 
comparison, Mio10 higher complexes are observed to migrate at a similar molecular 
size of the F1FO-ATPsynthase monomer and dimers. Moreover, it appears that Mio10 
may associate with the F1FOATPase dimer (V2) with a lesser extent to the monomer 
(V) and also what appears to be an intermediate complex.  
 



















Figure 20. Mio10 comigrates with F1FOATPase complexes. Radiolabeled Mio10 precursor 
was imported into isolated wildtype mitochondria in the presence or absence of membrane 
potential for the indicated times. Radiolabeled Atp21, Atp20 and Cox13 were also imported in 
parallel. All Samples were treated with proteinase K, solubilized in digitonin buffer, before 
complex separation by BN-PAGE (4-10% gradient gel). Protein complexes signals were 














                                                                                                                          RESULTS   
 63 
4.3.4 Analysis of Mio10 assembly in the absence of F1FOATPase dimers 
To verify Mio10 association with the F1FOATPase, a Mio10 radiolabeled precursor 
protein was imported into atp20∆ mitochondria, which lack an assembled F1FOATPase 
dimer due to the absence of the dimerization factor, Atp20 (Figure 21A). As a control, 
radiolabeled precursor of Atp21 was imported into atp20∆ or wildtype mitochondria. 
As expected, Atp21 assembles into the F1FOATPase dimeric and monomeric forms in 
wildtype mitochondria whereas in atp20∆ mitochondria, it exclusively assembles to 
the F1FOATPase monomer (Wagner et al., 2009). In parallel, Mio10 does not assemble 
into F1FOATPase dimer in atp20∆ mitochondria but rather shifts to the monomeric 
form; supporting the notion that Mio10 may be an F1FOATPase associated protein. 
Furthermore, analysis by BN-PAGE suggests the requirement of Atp20 for proper of 
Mio10 assembly.   
 
In order to rule out the possibility of post lysis association of Mio10 assembly 
into the F1FOATPase, a ‘Mix’ assembly assay was performed (Figure 21B). Mio10 
assembly was carried out as above into atp20∆ mitochondria and into wildtype 
mitochondria without addition of radiolabeled lysate (Mock); reactions were mixed 
before analysis by BN-PAGE (Figure 21C). If Mio10 association with the F1FOATPase 
were non-specific, then mixing the assembly reactions would give a positive signal 
corresponding to the dimer. As a control, Mio10 assembly in wildtype background was 
performed in juxtaposition. Results however indicated that the Mio10 large complexes 
continue to associate with F1FOATPase dimer ruling out possible non-specific 
association.  
 





Figure 21. Mio10 assembly requires the presence of Atp20. (A) Radiolabeled Atp21 and 
Mio10 precursor were imported into isolated wildtype and atp20∆ mitochondria in the 
presence or absence of membrane potential for the indicated times. (B) Schematic diagram 
describing ‘Mix’ assembly assay. (C) Mix assembly assay. Assembly was performed in WT 
and in atp20∆. A mock assay performed with no lysate added. After import, 
mitochondria were treated with PK. 50% of the atp20∆ assay sample was mixed with 
50% of the mock. Lane 3 overexposed for clarity. (A, C) All Samples were treated 
with proteinase K, solubilized in digitonin buffer, before complex separation by BN-
PAGE (4-10% gradient gel). Protein complexes signals were detected by digital 
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4.3.5 Second dimension analysis of Mio10 complexes in atp20∆ mitochondria 
Import and assembly of radiolabeled Mio10 indicated that Mio10 associates with what 
appears to be the F1FOATPase dimer in wildtype mitochondria, whereas this 
association is rendered absent in atp20∆ mitochondria that lack the F1FOATPase 
dimer. To investigate this observation further, a second dimension analysis of atp20∆ 
mitochondria was performed (Figure 22). In brief, wildtype and atp20∆ mitochondria 
were solubilized in digitonin buffer followed by separation of protein complexes on 
BN-PAGE. Individual lanes from the BN gel were sliced and further subjected to 
SDS-PAGE analysis (second dimension). The aim of the approach was to examine 
Mio10 signals in comparison to the F1FOATPase markers on second dimension as 











Figure 22. Mio10-containing complexes in atp20∆ mutants. Wildtype and atp20∆ 
mitochondria were solubilized in digitonin buffer, subjected to BN-PAGE (4-10% gradient 
gel). BN gel stripes were excised and subjected to SDS-PAGE. Signals were detected by 
Western blotting, V2, dimer; V, monomer; X, undefined.  
 
 
Immunoblotting for Atp2 or Atp5 enables detection of F1FOATPase monomers 
and dimers and thus a tool to assess status of dimerization. In wildtype mitochondria, 
Atp2 or Atp5 immunoblots indicate two large distinct points corresponding to the 
F1FOATPase monomer and dimer. In addition, Cox2 detection was used as a negative 
control and signals were unchanged in both wildtype and atp20∆ mitochondria. In 
atp20∆ mitochondria, Atp2 and Atp5 immunodetection yielded only on distinct signal 
corresponding to the F1FOATPase monomer. Moreover, checking for Mio10 in the 
wildtype indicates two distinct points similar to the Atp5 and Atp2, in agreement with 
the import and assembly results. However, the two Mio10 specific signals remain 
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present in atp20∆ mitochondria, indicating that the Mio10 high molecular sized 
complex (initially argued to be the F1FOATPase dimer and labeled ‘X’ in Figure 22) 
continues to appear even in the absence of properly assembled F1FOATPase dimer. 
Hence, second dimension analysis argues against Mio10 assembly and/or association 
with the F1FOATPase dimer as shown in the import and assembly assays. The Mio10-
containing complex may thus have similar molecular sizes to the F1FOATPase and 
comigrate in a similar fashion in BN-PAGE. 
 
4.3.6 Biochemical isolation of F1FOATPase components   
In a further attempt to demonstrate Mio10 F1FOATPase association, biochemical 
isolations from an Atp20zz strain (in which ProteinA was C-terminally fused to Atp20) 
were performed (Figure 23A). Immunoprecipitation was successful in co-isolating 
F1FOATPase subunits such as Atp5 and the Atp20zz bait. However, Mio10 was not co-
isolated with Atp20. Moreover, decorations for Cox2 (cytochrome c oxidase), Rip1 
(complex III) or Tom70 (TOM) were negative. All together, immunoprecipitation 
indicate that in disagreement with initial assembly results, Mio10 is not stably 




Figure 23. Mio10 and MINOS1 are not stably associated with the F1FOATPase. (A) 
Wildtype and Atp20zz mitochondria were solubilized and subjected to IgG- chromatography. 
Eluates were analyzed by SDS-PAGE and Western blotting. (B) Co-immunoprecipitations of 
cytochrome c oxidase (COX) and F1FOATPase components from isolated HEK29T 
mitochondria. Eluates were analyzed by SDS-PAGE and Western blotting.  
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To investigate whether MINOS1 associates with the F1FOATPase in higher 
eukaryotes, co-immunoprecipitations were performed from HEK293T mitochondria. 
Commercial antibodies specific to either the F1FOATPase (α-F1FO ATPase) or (α-
COX) as a negative control were used (Figure 23B). α-COX efficiently 
immunoprecipitates cytochrome c oxidase subunits COX1 and COX6A1 but not 
MINOS1, ATP2, or TIM23. In contrast, (α-F1FOATPase) antibodies successfully 
immunoprecipitated ATP2; but not MINOS1 or any of the negative controls. The 
results thus indicate that, as shown with Mio10 in yeast mitochondria, MINOS1 is also 
not stably associated with the F1FOATPase.  
 
4.4 MIO10 deletion mutant analysis  
As biochemical isolations indicated that Mio10 and MINOS1 do not associate with the 
F1FOATPase, a possible function in mitochondrial respiration and F1FOATPase activity 
was investigated. To this end, a MIO10 deletion strain (mio10∆), in which the 
YCL057c-A ORF was replaced by a kanamycin cassette (OpenBiosystems), was used. 
Any effect that the absence of Mio10 may have on F1FOATPase dimerization and 
oligomerization was also investigated. 
 
4.4.1 Growth analysis of MIO10 deletion mutant mitochondria 
To determine the effect of Mio10 on mitochondrial respiration, a growth behavior 
analysis was performed. Wildtype and mio10∆ cells were grown on fermentable 
(glucose) and non-fermentable (glycerol) medium plates at 30°C (Figure 24A). In 
addition, the non-respiring atp2∆ strain as well as atp20∆ mutants were used for 
comparison. A failure to grow on fermentable media may indicate respiratory chain 
function as shown for various respiratory chain mutants (Mick et al., 2010). Indeed, all 
strains grow as expected on glucose, meanwhile, the atp2∆ mutant, which lacks a 
functional F1FOATPase, fails to grow. The deletion of dimerization factors does not 
affect respiration, as the F1FOATPase monomers are still functionally active (Wittig 
and Schägger, 2009). However, both atp20∆ and atp21∆ mutants exhibit a weak 
phenotype when grown on non-fermentable medium (Arnold et al., 1998). 
Interestingly, both mio10∆ and atp20∆ appear to have similar slight growth 
impediments compared to wildtype and atp2∆ mitochondria. The results from the 
growth behavior analysis indicate that Mio10 may not be required for respiration. 
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4.4.2 Analysis of respiratory chain complexes in mio10∆  
The MIO10 deletion strain was used to further assess a Mio10 role in F1FOATPase 
assembly. Wildtype and mio10∆ mutant mitochondria were analyzed by BN-PAGE 
and Western blot analysis (Figure 24B). Immunodetection for the F1FOATPase protein, 
Atp5, indicates F1FOATPase dimerization is not affected in mio10∆ cells. Moreover, 
the absence of Mio10 does not affect complex III or cytochrome c oxidase assembly 
(indicated by immunodetection with Rip1 and Cox4 antibodies, respectively). Mio10 
thus appears not to have a role in the assembly of the F1FOATPase or other respiratory 





Figure 24. Mio10 is not required for mitochondrial respiration or supercomplex 
assembly. (A) Wildtype, mio10∆, atp20Δ and atp2Δ yeast cells were spotted in serial 10-fold 
dilutions on fermentable (glucose) and non-fermentable (glycerol) media. (B) Wildtype and 
mio10∆ mitochondria were solubilized in digitonin buffer, subjected to BN-PAGE (4-10% 











4.4.3 Assessment of F1FOATPase activity and oligomerization in mio10∆ mutants  
Mitochondrial respiratory chain complexes retain their enzymatic activity after 
separation by BN-PAGE (Wittig et al., 2007). To this end, an in-gel F1FOATPase 
activity assay was performed comparing wildtype and mio10∆ mitochondria (Figure 
25A). The in-gel activity assay (based on reverse action of the enzyme, ATP 
hydrolysis) indicates that F1FOATPase activity is comparable in wildtype and mio10∆ 
mitochondria and is unaffected by the MIO10 deletion. Furthermore, neither 
cytochrome c oxidase nor complex I activities were significantly affected.   
 
Given that most of the analysis performed in this study so far focused on 
F1FOATPase dimerization, the effect on higher F1FOATPase oligomers should be not 
be disregarded. To this end, an in gel F1FOATPase activity assay was performed on a 
modified BN gel to better separate higher F1FOATPase oligomers (Figure 25B). As a 
control, atp20∆ were again used in parallel with fcj1∆ mitochondria. Deletion of FCJ1 
augments the stability of higher F1FOATPase oligomers (Rabl et al., 2009). A modified 
in-gel activity assay in which digitonin buffer conditions and the BN-PAGE gel 
gradient were altered. The assay revealed various bands corresponding to the 
F1FOATPase monomer, dimer, and higher oligomers. Whereas atp20∆ mitochondria 
have an increased pool of F1FOATPase monomer (at 669 kDa), there are no other 
apparent discrepancies between the other strains. It is thus evident, based on the in-gel 
activity assay, that there is no change in F1FOATPase oligomerization in mio10∆ 
mitochondria compared to wildtype mitochondria. As F1FOATPase activity was also 
not affected or did Mio10 (and MINOS1) associate with F1FOATPase, results indicate 
that neither Mio10 nor MINOS1 are F1FOATPase dimerization factors. 
 




Figure 25. F1FOATPase activity and oligomerization are not affected in mio10∆ mutants. 
(A) Wildtype and mio10∆ mitochondria were solubilized in 1% digitonin buffer and subjected 
to BN-PAGE (4-10% gradient gel). In-gel activity assays were carried out as described in 
Materials and Methods. (B) Wildtype, mio10∆, fcj1∆, and atp20∆ mitochondria were 
solubilized in 0.35% digitonin buffer and subjected to BN-PAGE (3-13% gradient gel). In-gel 
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4.5 Identification of Mio10 and MINOS1 interaction partners  
Results so far indicate that Mio10 and MINOS1 are not involved in F1FOATPase 
dimerization, oligomerization, or activity. A function of the proteins remains unclear. 
To this end, interaction partners of Mio10 and MINOS1 were isolated and analyzed by 
mass spectrometry with the objective of elucidating Mio10/MINOS1 functions. 
  
4.5.1 Identification of Mio10 interaction partners  
In order to identify interaction partners of Mio10, the MIO10 ORF was C-terminally 
tagged with a streptavidin tag followed by a FLAG tag (SF). Yeast cells were 
harvested and mitochondria were isolated. Using the Mio10SF, a large-scale protein 
isolation was performed via the streptavidin tag, and eluates were analyzed by mass 
spectrometry. First, eluates from the Mio10SF isolation were subjected to SDS-PAGE 
and the gel was stained with coomassie. The SDS-PAGE was cut into 23 slices, which 
were then analyzed by high-resolution online liquid chromatography-tandem mass 
spectrometry (LC-MS/MS). Co-isolated proteins were scored based on the normalized 
fold change calculated using a label-free spectral count approach. Table 7 indicates 
specific interacting proteins with highest spectral counts, in which a normalized fold 
change cut-off of 0.1 was applied. The normalized fold change was calculated based 
on spectral counts of a specific protein and total spectral counts for all proteins in the 
sample. Besides the bait Mio10, Fcj1, which is involved in mitochondrial cristae 
formation and maintenance, had the highest sample spectral count (Rabl et al., 2009). 
Moreover, none of the highest scoring proteins were F1FOATPase associated proteins.  
 
Indeed, the LC-MS/MS results provide a wide range of proteins, of both 
characterized and previously uncharacterized functions. Characterized proteins 
identified in the analysis range from cytochrome c oxidase components (Cox20), to 
mitochondrial import (Pam17), mitochondrial translational regulation (Mdm38), and 
mitochondrial ribosomal proteins (Mrpl27). These proteins, however, gave low 
spectral counts and their identification might be a result of nonspecific binding to the 
column. Interestingly, many of the highest scoring proteins (YGR235C, Aim37, 
Aim13, Aim46, Aim5, and Aim24), are previously uncharacterized and may be 
potential interacting partners of Mio10. The AIM (Altered Inheritance of 
Mitochondria) proteins were found by a computational screen to play a role in 
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mitochondrial biogenesis and inheritance (Hess et al., 2009). Their interaction with 
Mio10 may indicate a possible role of Mio10 in mitochondrial inheritance. 
 
 
Table 7. Identified proteins of the Mio10SF StrepTactin-chromotography. The raw 
MS files were searched and analyzed with Mascot (Mascot Deamon version 2.2.2, 
Matrix Science) and Scaffold 3 (Proteome Software) using the S. cerevisiae NCBI 
non-redundant protein database. The normalized fold change ratios were then 
calculated in Scaffold using the spectral count approach (Liu et al., 2004). Mass 
spectrometric analysis performed by Monika Raabe and Miroslav Nikolov (AG 
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Figure 26. Mio10 interacts with Fcj1. (A) Wildtype and Mio10SF mitochondria were 
solubilized and subjected to Strep-Tactin chromatography. Eluates were separated by SDS-
PAGE and gels were coomassie stained. (B) Eluates from Strep-Tactin chromatography were 
analyzed by SDS-PAGE and Western blotting. (C) Wildtype and Fcj1zz mitochondria were 




The protein composition of coomassie stained bands was identified due to the 
availability of spectral counts for each slice. Figure 26A depicts the coomassie stained 
gel used for LC-MS/MS analysis, in which coomassie stained bands corresponding to 
Fcj1 and Mio10 were annotated. The results from the Mio10SF complex isolation and 
consequent analysis indicated that Fcj1 co-isolates with Mio10. To further verify this, 
eluates from the Mio10SF isolation were separated on an SDS-PAGE and subjected to 
Western blot analysis (Figure 26B). Immunoblotting for Fcj1, indicate a clear band in 
Mio10SF eluate and a lack of signal in the wildtype control, thus verifying results from 
the mass spectrometry. Moreover, immunodetection for Atp5 verified that the 
F1FOATPase is not significantly isolated with Mio10, whereas negative controls such 
as respiratory chain proteins; Cyt1 (complex III) and Cox2 (cytochrome c oxidase) and 
mitochondrial import machinery (Tom70 and Tim44) were all absent. Moreover, 
Western blot analysis indicates that the Mio10SF strain does not contain any 
endogenous non-tagged Mio10. To further confirm Fcj1 interaction with Mio10, 
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mitochondrial proteins were immunoprecipitated from an Fcj1zz strain (Figure 26C). 
Results confirm that Mio10 co-isolates with Fcj1, whereas controls such as Atp5, 
Cox2, Tom70, and Tim44 were negative. A Mio10 interaction with Fcj1 may indicate 
a role in cristae biogenesis (Rabl et al., 2009).  
 
4.5.2 Identification of MINOS1 interaction partners  
Isolation of Mio10-containing complexes followed by mass spectrometric analysis 
revealed that Mio10 interacts with Fcj1 rather than the F1FOATPase as originally 
hypothesized. To investigate whether the interaction is conserved across higher 
eukaryotes, a SILAC (stable isotope labeling of amino acids in cell culture) combined 
with mass spectrometry approach was carried out (Figure 27). SILAC makes use of 
differential isotope labeling to achieve quantitative based mass spectrometric analysis, 
and has been proven useful in various proteomic applications (Ong et al., 2002; Ong 
and Mann, 2006). In brief, HEK293T cells were grown in media containing either light 
or heavy labeled lysine and arginine. Cultured cells were then harvested, mitochondria 
isolated, and consequently solubilized in a mild digitonin buffer. MINOS1-containing 
mitochondrial protein complexes were then immunoprecipitated by a MINOS1 
specific antibody from heavy isotope containing cells, whereas a control antibody was 
used to immunoprecipitate proteins from light isotope containing cells. Eluates from 
cells with light or heavy isotope containing medium were combined and subjected to 
SDS-PAGE analysis; at which point the coomassie stained gel was sliced and subject 
to LC-MS/MS. In addition, for statistical analysis and to rule out possible false 
positives/negatives, the reverse (label switch) experiment was performed. In this case, 
MINOS1-specific antibodies were used to immunoprecipitate light isotope containing 
cells, whereas unspecific antibodies were used for the heavy isotope containing cells.  
 
Spectral counts normalized ratios of heavy-over-low (H/L) for the forward and 
reverse experiments are presented in (Figure 28A). Enriched proteins, which satisfy 
the set threshold of 2.0, are labeled with a red dot whereas nonspecific/non enriched 
(under threshold of 2.0) are labeled with blue dots. The dot-blot clearly indicates that 
Mitofilin (human homolog of Fcj1) has the highest score, supporting the notion that 
the Mio10-Fcj1 interaction in yeast is conserved in human. Interestingly, mass 
spectrometric analysis also indicates that many of the known Mitofilin interacting 
proteins: CHCHD3, HSPA9, and DNJAC1, SAM50, MTX1, and MTX2 (green dot 
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with red circumference) are also immunoprecipitated with Mitofilin (Xie et al., 2007; 
Darshi et al., 2011). In addition, various other mitochondrial and non-mitochondrial 
proteins were enriched with MINOS1. Some of these interactions were verified by 
Western blot analysis of the immunoprecipitated protein samples (Figure 28B). 
MINOS1 specific antibodies (α-MINOS1) efficiently precipitated MINOS1, Mitofilin 
(IMMT), CHCHD3, and HSPA9 compared to the control antibodies. In parallel to 
yeast mass spectrometric analysis, MINOS1-specific antibodies do not precipitate the 
F1FOATPase ATP2 protein, further indicating that MINOS1 is not an F1FOATPase 
associated protein. Other possible interactions could not be verified due to the 
unavailability of antibodies. Nonetheless, mass spectrometric analysis of MINOS1 
interactions indicate that MINOS1 interacts with Mitofilin, indicating that the 

















Figure 27. Schematic of the SILAC approach and mass spectrometric analysis. Figure 
courtesy of Markus Deckers. HEK29T cultured cells were grown in either Light or Heavy 
isotope containing medium. Mitochondria from each culture were isolated, solubilized and 
complexes were immunoprecipitated with either MINOS1 specific antibodies or control 
antibodies. After washing elutions were mixed and subjected to SDS-PAGE. The gel was cut 
into 23 equal and in-gel trypsinization was performed, followed by LC-MS/MS analysis.  




Figure 28. MINOS1 interacts with Mitofilin. Identification of MINOS1 associated proteins 
by co-immunoprecipitation and SILAC-MS. (A) RAW MS files from LC-MS/MS were 
analyzed by MaxQuant and Mascot using the IPI human protein database. Red dots indicate 
enriched proteins characterized by a high normalized ratio of heavy over light values (H/L). 
Forward F (H=MINOS1/L=Control), Reverse R (H=control/L=MINOS1, reverse ratios were 
inversed for plotting). Green dots with red circumference indicate known Mitofilin interacting 
proteins. (B) Isolated mitochondria from HEK293T cells were solubilized and subjected to Co-
immunoprecipitation with MINOS1 and control antibodies. Eluates were separated by SDS-
PAGE and analyzed by Western blotting. IMMT, Mitofilin. Mass spectrometric analysis 




4.6 Characterization of Mio10 and MINOS1 interaction with Fcj1 and 
Mitofilin   
 
To assess Mio10 and MINOS1 with respect to Fcj1 and Mitofilin complexes, 
solubilized wildtype mitochondria were subjected to size exclusion chromatography. 
Proteins were eluted in 12 fractions and subjected to SDS-PAGE and Western blot 
analysis (Figure 29A). Mio10 appears to form various sized complexes: a smaller 
complex at approximately 232 kDa (fraction 8) and a larger complex at approximately 
1.2 MDa (fraction 3). The same holds true when examining Fcj1-containing 
complexes, which appear to elute at the same fractions as Mio10. This further supports 
the Fcj1 and Mio10 interaction. Moreover, it may be inferred from the size exclusion 
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chromatography that together, both Mio10 and Fcj1 form a large complex. It appears 
that the complex is larger than respiratory chain complexes formed by cytochrome c 
oxidase and F1FOATPase as indicated by immunoblotting for Cox1 and Atp5 
respectively. Furthermore, F1FOATPase signals (Fractions 4-7) are devoid of Mio10 




Figure 29. Mio10/Fcj1 and MINOS1/Mitofilin form large mitochondrial complexes. 
Wildtype yeast (A) and HEK29T (B) mitochondria were solubilized and subjected to size 
exclusion chromatography using a ÄKTApurifier system (GE Healthcare). The resulting 
fractions from the ÄKTApurifier system were TC precipitated, dried and subjected to SDS-
PAGE and Western blotting. IMMT= Mitofilin. 
 
 
MINOS1 containing complexes were analyzed as well by size exclusion 
chromatography (Figure 29B). In parallel to Mio10 in yeast, MINOS1 forms as well a 
large predominant protein complex of approximately 1 MDa (fractions 3-4), whereas a 
smaller complex is absent. Mitofilin also appears to form a large complex in the MDa 
range (fraction 2-5), predominantly in fraction 4 and thus appears in complex with 
MINOS1. The size of the MINOS1/Mitofilin complex appears to be distinctive from 
cytochrome c oxidase containing complexes (fraction 7) and F1FOATPase complexes 
(fraction 5). The results from size exclusion chromatography thus indicate that Mio10 
and MINOS1 are part of a large mitochondrial complex that contains Fcj1 in yeast and 
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4.7 Investigation of the role of Mio10 in mitochondrial morphology 
 
As mass spectrometric analysis of yeast and human mitochondria in combination with 
size exclusion chromatography indicate that Mio10 and MINOS1 interact with Fcj1 
and Mitofilin in large mitochondrial complexes. Previous reports indicate that Fcj1 and 
Mitofilin are involved in cristae biogenesis and inner membrane morphology (John et 
al., 2005; Rabl et al., 2009). The question, whether Mio10 or MINOS1 are also 
involved in mitochondrial inner membrane organization, was asked. Due to the 
availability of established tool and deletion strains, a role of the proteins were 
investigated primarily in yeast. MIO10 deletion strains were again used to investigate 
whether Mio10, like Fcj1 is also involved in mitochondrial morphology. MIO10 and 
FCJ1 deletions strains were further analyzed by live-cell fluorescence microscopy and 
electron microscopy. In all cases, an ATP20 deletion strain was also analyzed for 
comparison.  
 
4.7.1 Growth test: SG /SD medium at 18°C 
MIO10 and FCJ1 deletion mutant cells were grown on minimal glucose (SD) and 
minimal glycerol (SG) medium plates at non-permissive temperatures of 18°C, 37°C, 
as well as 30°C (Figure 30). Mutant fcj1∆ cells have been shown to exhibit a growth 
defect when grown on YLac in which deletion of FCJ1 leads to altered mitochondrial 
inner membrane morphology, mainly by affecting numbers of cristae tips (Rabl et al., 
2009). Growth behavior analysis with SD and SG were used to enforce stringent 
growth conditions. Indeed, mutations affecting inner membrane stability are more 
potent at low or high non-permissive temperatures (Brandner et al., 2005; Rabl et al., 
2009). Whereas wildtype and mutant cells all grow similarly on SD, differences are 
exhibited mainly when grown on SG medium. At 30°C, mio10∆, atp20∆, and fcj1∆ 
exhibit an impeded growth compared to wildtype cells on SG medium. Moreover, 
stark differences can be observed at 18°C SG, at which mio10∆ and fcj1∆ exhibit a 
strong growth defect, while atp20∆ cells exhibit a weaker phenotype.  At higher 
temperatures, 37°C, mutant cells again exhibit a growth phenotype, although not as 
prominent as in 18°C. The similarity in mio10∆ and fcj1∆ highlights a possible genetic 
and/or functional relationship. As growth on SG, is not completely inhibited at 30°C or 
37°C, a role in mitochondrial respiration is considered unlikely.  
 









Figure 30. MIO10 and FCJ1 deletion mutants’ growth defect at low temperatures. 
Wildtype, mio10∆, and fcj1∆ yeast cells were spotted in serial 10-fold dilutions on minimal 
fermentable (SD) and non-fermentable (SD) minimal media. Cells were grown at 18°C, 30°C, 
and 37°C.  
 
 
4.7.2 Protein steady state analysis of mitochondria grown at 18°C  
Mitochondria were harvested from MIO10 and FCJ1 deletion mutant cells grown at 
18°C in SG medium. The steady-state protein levels were analyzed by SDS-PAGE 
(Figure 31A) and BN-PAGE (Figure 31B). The deletion strains are confirmed by the 
absence of Mio10 and Fcj1 signals in respective strains. One should note a signal 
detection migrating above Fcj1 signal in fcj1∆ cells; this corresponds to an antibody 
cross reaction rather than residual Fcj1 protein. Moreover, Fcj1 protein levels appear to 
be slightly reduced in mio10∆ compared to wildtype. This effect, however, is not 
paralleled in fcj1∆ mutant cells, which have levels of Mio10 comparable to wildtype 
cells. Furthermore, steady-state levels of respiratory chain proteins (Rip1, Cty1, Cox2, 
Atp5) are not affected, whereas outer membrane proteins (Tom70, Porin) and the inner 
membrane protein Tim21 are also unaffected by the absence of Mio10 or Fcj1.  
Assembly of respiratory chain complexes in mio10∆ grown at 18°C in SG medium 
was accessed by BN-PAGE, at which assembly of the F1FOATPase and complex III 
appear unaffected.   




Figure 31. Protein steady-state levels are unaffected in mio10∆ mutants. (A) Wildtype, 
mio10∆, and fci1∆ mitochondria were subjected to SDS-PAGE and Western blotting. (B) 
Wildtype and mio10∆ mitochondria were solubilized in digitonin buffer, subjected to BN-
PAGE (4-10% gradient gel) and Western blotting.  
 
 
4.7.3 Live-cell fluorescence microscopy analysis of mio10∆ mitochondria 
Mitochondria form interconnected dynamic networks of which phenotypic 
characteristics are dependent on the metabolic state of the cell and a balance between 
the processes of mitochondrial fission and fusion (Okamoto and Shaw, 2005). The 
organization of the mitochondrial network of mio10∆ mutant yeast cells was visualized 
by live-cell imaging (Figure 32), in which yeast cells were transformed with a 
mitochondrial localized GFP expressing plasmid, pVTU100U-mitoGFP (Westermann 
and Neupert, 2000). This allows contrasting bright fluorescent mitochondria against 
clear background staining, and thus proper assessment of network morphology. 
Wildtype mitochondria display a typical reticular mitochondrial network which 
transverses the majority of the cell. On the other hand, atp20∆ mutant cells exhibit 
atypical networks characterized by thickened and fragmented mitochondria. Upon 
analysis of both mio10∆ and fcj1∆ mutant cells, it is evident that they share a similar 
mitochondrial network organization. In both cases, mitochondrial networks appeared 
on the periphery of cell and more condensed than in the atp20∆ counterpart strain. 
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Indeed, analysis of fcj1∆ mitochondria is in agreement with previously published 
observations (Rabl et al., 2009). The similarities observed in the mitochondrial 
networks for mio10∆ and fcj1∆ strains may support the notion of a functional 




Figure 32. Mitochondrial morphology is altered in mio10Δ. Yeast wildtype, atp20Δ, 
mio10Δ and fcj1Δ cells transformed with plasmid pVT100U-mitoGFP and analyzed by 
fluorescence microscopy. Scale Bars, 2.5µm. Microscopy was performed by Daniel Jans (AG 
Jakobs, MPI-bpc, Göttingen). 
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4.7.4 Analysis of mio10∆ mitochondria by electron microscopy  
The mitochondrial cristae morphology of wildtype and mutant yeast cells were further 
assessed with the use of electron microscopy coupled with high-pressure freezing, 
HPF, in order to preserve intact cellular structure (Figure 33A). Wildtype cells contain 
mitochondria with typical tubular cristae membranes whereas atp20∆ mitochondria 
appear to have the distinctive ‘onion-like’ inner membrane organization, previously 
shown for atp20 and atp21∆ mutants (Paumard et al., 2002; Arselin et al., 2004).  
Mitochondria of the ATP20 deletion mutant contain two or three lamellar cristae 
membranes, which span the entire organelle in a spherical manner. In contrast, analysis 
of mio10∆ and fcj1∆ mitochondria indicated atypical yet less severe phenotype 
characterized by more compact transversion of the inner membrane. Moreover, in 
mio10∆ and fcj1∆ cells, mitochondria appear to localize to the periphery of the cells, 
reflecting observations by live-cell fluorescent imaging.  
 
The distinctive mitochondrial phenotypes observed from electron microscopy 
images where further subjected to a quantitative analysis to better define the various 
mutants (Figure 33B). An average of 55 images from each strain was used in the 
analysis, which is based on the percentage of analyzed cells that contain the various 
phenotypes.  The tubular wildtype phenotype was termed ‘normal’, where as onion-
like phenotype as simply ‘onion-like’. The atypical phenotypes observed in mio10∆ 
and fcj1∆ were termed ‘intermediate’.  Quantification of the various mutant 
phenotypes indicates that a large majority (approximately 90%) of wildtype 
mitochondria favor ‘normal’ inner membrane arrangements with 10% having either 
intermediate or onion-like structures. Interestingly, unlike the wildtype cells, none of 
the mutants appeared to have a similar inclination to one single phenotype and 
appeared to contain all three phenotypes in varying amounts.  For instance, whereas 
atp20∆ mitochondria tend to have ‘onion-like’ organization, approximately 50% had 
either normal or intermediate. The same holds true for fcj1∆ mutants, in which 
approximately 50% of the cells tend to have an ‘intermediate’ phenotype, with the 
other 50% either ‘normal’ or ‘onion-like’.   In contrast, mio10∆ mutants tend to favor 
‘intermediate’ and ‘onion-like’ inner membrane organizations in rather similar 
quantities meanwhile approximately 20% were ‘normal’ in both strains. 
 
 








Figure 33. Aberrant cristae morphology in mio10∆ mitochondria. (A) Electron microscopy 
of yeast wildtype, atp20Δ, mio10Δ and fcj1Δ cells after high pressure freezing (HPF). Bars, 1 
µm. (B) Quantitative analysis of different types of mitochondria phenotypes based on electron 
microscopy images from HPF fixed cells; wildtype WT (n=49), atp20Δ (n=51), mio10Δ 
(n=61) and fcj1Δ (n= 57) cells. Detailed view representation of normal, intermediate and 
onion-like mitochondria types. Microscopy and analysis were performed in collaboration with 
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In order to have an improved visualization of mutant mitochondria inner 
membranes, cells were chemically fixed with KMnO4 before analysis by electron 
microscopy (Figure 34). Fixation by KMnO4 allows the ‘unmasking’ of protein-
phospholipids complexes generating a higher membrane contract in electron 
micrographs (Bradbury 1960). Under these conditions, mitochondria from the atp20∆ 
strain again have the onion-like organization characterized by clear various concentric 
layers of inner membrane. Moreover, atp20∆ mitochondria appear to have poorly 
defined cristae, compared to the defined tubular cristae membrane in the wildtype 
strain. Conversely, mio10∆ and fcj1∆ mitochondria contain closely stacked lamellar 
membrane sheets which transverse horizontally the organelle (rather than spherical 
transversions of the atp20∆ mutants). Furthermore, mio10∆ and fcj1∆ contain no 
cristae and appear to lack any recognizable cristae tips.    
  
 
The results from the electron microscopy analysis of HPF and KMnO4 fixed 
cells indicate that Mio10 plays a functional role in mitochondrial inner membrane 
organization. The ORF YCL057c-A is thus referred to Mio10 for mitochondrial inner 
membrane organizer, whereas its human homolog is referred to MINOS1, for 
mitochondrial inner membrane organizing system 1. The combination of topological 
analysis, mass spectrometric analysis and size exclusion chromatography, indicate that 
Mio10 and MINOS1 are novel interacting partners of Fcj1 and Mitofilin, and form a 
large inner membrane complex. This complex is termed MINOS, for Mitochondrial 
Inner membrane Organizing System. Mio10 and MINOS1 do not associate with the 
F1FOATPase or play a role in its dimerization. However by forming the MINOS 
complex, Mio10 and MINOS1 appears to play an essential role in cristae morphology 













Figure 34. Absence of apparent cristae and cristae tips in mio10∆ mitochondria. (A) 
Electron microscopy analysis of wildtype, atp20Δ, mio10Δ and fcj1Δ cells after KMnO4 
fixation. Scale bars, 200 nm. (B) Detailed view of WT, atp20Δ, mio10Δ and fcj1Δ 
mitochondria showed in (A). Microscopy and analysis were performed in collaboration with 
Wolfgang Schliebs (Ruhr Universität Bochum) 




5. DISCUSSION  
 
In this study, an initial in silico approach to identify novel F1FOATPase dimerization 
factors resulted in the identification of the yeast mitochondrial protein Mio10 as a 
potential candidate. Mio10, along with its human homolog, MINOS1, were 
investigated. These proteins were found to display a function unrelated to dimerization 
of F1FOATPase, and are instead novel factors involved in the maintenance of 
mitochondrial cristae morphology. Whereas recent studies have in parallel identified 
Mio10 in yeast, this is the first study that has identified MINOS1 as a novel interaction 
partner of Mitofilin in higher eukaryotes. The presented findings highlight the 
functional and evolutionary significance of the MINOS complex as a player in 
mitochondrial inner membrane architecture and as multifunctional component in 
eukaryotic mitochondria and potentially in other cellular organelles. 
 
5.1 Mio10 and MINOS1 are not F1FOATPase dimerization factors 
 
5.1.1 Identification of the inner membrane proteins: Mio10 and MINOS1  
F1FOATPase synthase dimers have been identified in various organisms ranging from 
yeast, mammals, and plants (Straus et al., 2008; Davies et al., 2011). Dimerization has 
various structural and functional roles. It contributes to the F1FOATPase holo-enzyme 
structure and plays a regulatory role in conditions of low electron transfer activity and 
reduced membrane potential (Buzhynskyy et al., 2007, Wittig and Schägger, 2009). 
Moreover, F1FOATPase dimerization is also involved in the maintenance and 
biogenesis of cristae membranes (Giraurd et al., 2002; Paumard et al., 2002b; Gavin et 
al., 2004; Dudkina et al., 2006; Rak et al., 2007; Velours et al., 2009). Several 
F1FOATPase subunits, such as subunit a, b, h, and y, have been shown to contribute to 
dimerization in yeast and higher eukaryotes (Soubannier et al., 2002; Fronzes et al., 
2003). In addition, several small FO interacting membrane proteins (Atp18, Atp19, 
Atp20, and Atp21) mediate dimeric interactions by binding sequentially at monomer 
interfaces in yeast (Arnold et al., 1997, 1998; Soubannier et al., 2002; Paumard et al., 
2002a; Wagner et al., 2009, 2010). In contrast, these small dimerization factors have 
not been found in higher eukaryotes. Homologs of Atp20 and Atp21 are found in 
H.sapiens, however a functional role in F1FOATPase dimerization has not been 
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identified. The exact nature of what promotes F1FOATPase monomer-monomer 
interactions and therefore dimerization is elusive and yet to be determined. To this end, 
the initial aim of this study was to identify novel F1FOATPase dimerization factors in 
higher eukaryotic organisms that parallel the action of small dimerization factors in 
yeast. 
 
In order to identify new dimerization factors, an in silico based analysis was 
performed based on characteristics of the primary amino acid sequences of identified 
factors. This included a protein with a small molecular size (less than 12 kDa) and at 
least one transmembrane domain. Subsequently, selecting proteins with GxxxG motifs 
and significant potential homologs narrowed search results down. The GxxxG motifs 
that are found in both Atp20 and Atp21, allow helix-helix membrane interactions with 
neighboring proteins (Russ and Engelman, 2000). Moreover, the GxxxG motif of 
Atp20 and Atp21 is critical for their role in dimerization (Arselin et al., 2003). The 
results of the in silico analysis yielded the ORF, YCL057c-A (Mio10). Blast search of 
the Mio10 primary amino acid sequence identified a potential human homolog, 
C1orf151 (MINOS1). The in silico analysis indicated a second potential dimerization 
factor, however Mio10/MINOS1 were selected based on the evidence that Mio10 
(YCL057c-A) has been previously identified in large-scale proteomic screens and 
predicted to have a mitochondrial localization and that MINOS1 (C1orf151) has been 
found in a computational screen for regulators of oxidative phosphorylation (Sickmann 
et al., 2003; Reinders et al., 2006; Baughman et al., 2009). To this end, Mio10 and 
MINOS1 were then characterized biochemically and functionally. 
 
The F1FOATPase dimerization factors are membrane proteins that interact with 
the inner membrane embedded FO domain of F1FOATPase (Wagner et al., 2010). In 
order to investigate a possible role dimerization, the association of Mio10 and 
MINOS1 with the inner membrane was thus investigated. Subfractionation analysis 
was performed in tandem with membrane association assays using isolated yeast 
mitochondria. The results indicated that Mio10 is indeed an integral protein of the 
inner membrane. It was also inferred that Mio10 localizes to the inner membrane in a 
manner that its N and C termini are exposed to the IMS. One should note that this 
topology is based on the hypothetical model that Mio10 contains two transmembrane 
domains. Additional analysis is thus required to verify N terminal exposure to the IMS. 
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This may include raising antibodies that specifically recognize the N terminus of 
Mio10. Furthermore, subfractionation analysis and membrane association assays of the 
human MINOS1 have also been performed using isolated human mitochondria from 
cultured HEK293T cells. The MINOS1 mitochondrial localization was also shown by 
confocal microscopy. These results indicated that MINOS1 is also a mitochondrial 
inner membrane protein that has membrane topology similar to yeast homolog.  
 
5.1.2 Mio10 and MINOS1 complexes comigrate but not physically associate with 
the F1FOATPase  
 
To assess Mio10 and MINOS1 containing complexes, solubilized mitochondria were 
subjected to BN-PAGE after import and assembly. This approach has proven 
previously useful in the characterization of F1FOATPase dimerization factors, as BN-
PAGE can be utilized to investigate large membrane-bound protein complexes under 
native conditions (Schägger and von Jagow, 1991; Nijtmans et al., 2002, Wagner et 
al., 2009, 2010). Radiolabeled Mio10 and MINOS1 precursors were synthesized in 
vitro and imported in yeast and human mitochondria. Mitochondria isolated from 
HEK293T human cultured cells were used as a representative model of higher 
eukaryotes. Upon analysis by BN-PAGE, both Mio10 and MINOS1 precursors were 
imported into either yeast or human mitochondria as well as assemble into complexes 
of various sizes, ranging from small (approximately 160 kDa) to large complexes 
(larger than 669 kDa). The observation that both protein precursors can be 
interchangeably imported into both yeast and human mitochondrial systems may 
reflect a high level of functional conservation. Indeed, sequence analyses of Mio10 and 
MINOS1 across various species indicated a high level of conservation mainly 
clustered at predicted transmembrane domains and particularly at the GxxxG motifs. 
Interestingly, both the N and C termini are not conserved. This may reflect that 
function and perhaps mitochondrial targeting and/or import are most likely dependent 
on the proteins’ central domains. The notion whether Mio10 and MINOS1 can 
functionally complement each other is yet to be determined. Preliminary 
complementation assays, in which the MINOS1 coding gene was expressed under 
various promoters in a MIO10 deletion mutant, did not overcome growth defects 
observed (data not shown). Although MINOS1 does express in yeast as found by 
Western blot analysis, the failure to complement may be due to insufficient levels of 
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MINOS1 overexpression and thus further optimizations are necessary. This may also 
indicate that whereas sequence differences may allow import of Mio10 and MINOS1 
into in different species, these differences may not allow functional complementation.  
 
Upon further analysis by BN-PAGE in which Mio10 radiolabeled precursor 
was imported in parallel with respiratory chain proteins, it appeared that the large 
Mio10 containing complexes comigrated with the F1FOATPase dimer. In contrast, 
Mio10 containing complexes appeared larger than complex III or cytochrome c 
oxidase containing complexes. Moreover, Mio10 import and assembly appeared to be 
dependent on the presence of the F1FOATPase dimerization factors Atp20. In this case, 
the large Mio10 containing complexes failed to assemble in atp20∆ mitochondria. The 
effect was also shown to be specific to atp20∆ mitochondria and not due to 
nonspecific post lysis association. It should be noted that due to limitations of α-
MINOS1 and α-Mio10 antibodies to recognize native epitopes on BN-PAGE, it was 
difficult to verify import and assembly results by Western blot analysis. As an 
alternative, second dimension analysis by SDS-PAGE was used. Surprisingly, second 
dimension analysis of Mio10 containing complexes in atp20∆ mitochondria revealed 
that the large Mio10 complex continues to be present in the absence of the 
F1FOATPase dimer. This indicates that the Mio10 containing complex is different from 
the F1FOATPase dimer. The Mio10 complex may thus have a similar size to the 
F1FOATPase and may thus have similar migration properties on BN-PAGE. The 
Mio10 assembly defect in atp20∆ may possibly be an artifact. The severe effects that 
ATP20 deletion mutants have on the organization of the mitochondrial inner 
membrane may be a possible explanation for this. However, it is unclear why this 
specifically affects Mio10 assembly and not other F1FOATPase components, such as 
Atp21, which assemble to the F1FOATPase dimer as expected. In summary, analysis of 
Mio10 containing complexes by BN-PAGE indicates that the presence of Mio10 
complexes is independent of the F1FOATPase. 
 
5.1.3 Mio10 and MINOS1 are not stably associated with the F1FOATPase  
In order to further investigate a possible Mio10 association with the F1FOATPase, a 
tagged Atp20 strain (Atp20zz) was used to biochemically isolate the F1FOATPase and 
its associated components. Indeed, immunoprecipitation was successful for 
F1FOATPase components such as Atp5, proving the technical success of the approach. 
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However, Mio10 was not coisolated. These isolations were repeated using a 
streptavidin-flag C-terminally tagged Atp5 or Atp20 and with co-
immunoprecipitations with Mio10 specific antibodies (data not shown). In all cases, 
Mio10 was not coisolated with the F1FOATPase components. As solubilization buffer 
conditions and salt concentrations used in biochemical protein isolations from yeast 
differed from those used in BN-PAGE assembly experiments, it was taken into 
account that a higher salt concentration used in biochemical isolations may explain the 
lack of stable Mio10 association with the F1FOATPase. To compensate for these 
changes, immunoprecipitation with the Atp20zz tagged strain was repeated with BN-
PAGE conditions. However, Mio10 was not coisolated with F1FOATPase subunits 
under these conditions (data not shown). In addition, the F1FOATPase and its 
associated components were co-immunoprecipitated from HEK29T3 isolated 
mitochondria using F1FOATPase specific antibodies. MINOS1 was not found to 
associate with the F1FOATPase whereas the approach was successful in isolating Atp2. 
Thus, the biochemical isolations from yeast and human isolated mitochondria indicate 
that neither Mio10 nor MINOS1 are stably associated with the F1FOATPase and thus 
may not have a role in its dimerization.  
 
5.1.4 Mio10 does not affect F1FOATPase activity or oligomerization   
Analysis of the growth behavior of the F1FOATPase dimerization factors indicates that 
they are not essential for mitochondrial respiration or F1FOATPase activity, (Arnold et 
al., 1998; Paumard et al., 2002a; Soubannier et al., 2002). To assess the any effect a 
MIO10 deletion may have on mitochondrial respiration, yeast mio10∆ cells were 
grown in fermentable and non-fermentable media. In fact, mio10∆ cells continue to 
grow on non-fermentable medium and have a similar growth profile as atp20∆ cells. 
Mitochondrial respiration does not seem to be compromised in mio10∆ mutants in 
comparison with atp2∆ cells. Atp2 is the beta subunit of the F1FOATPase and together 
with Atp1 form the catalytic core in the F1 component (Takeda et al., 1985; Abrahams 
et al., 1994). In addition, an in-gel activity assay was used to assess the effect of 
MIO10 deletion on the activity of various respiratory chain complexes. Absence of 
Mio10 does not affect the enzymatic activity of F1FOATPase, cytochrome c oxidase, or 
complex I. Therefore, it is concluded that Mio10 is not involved in F1FOATPase 
activity or mitochondrial respiration.  
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Using the mio10∆ strain, a possible role for Mio10 in F1FOATPase 
dimerization was further assessed by BN-PAGE and Western blot analysis. 
Immunodetection for Atp5, which allowed the detection of F1FOATPase complexes, 
indicated the presence of intact F1FOATPase dimers. Thus the absence of Mio10 does 
not affect dimerization. Various inner membrane proteins such as Fcj1 and its C. 
elegans homolog, IMMT-2, do not play a role in dimerization but affect the stability of 
the F1FOATPase higher oligomers (Rabl et al., 2009; Mun et al., 2010). IMMT-2 was 
suggested to be involved in the formation of supermolecular complexes (Mun et al., 
2010). On the other hand, FCJ1 overexpression reduces the stability F1FOATPase due 
to its antagonistic effect on F1FOATPase dimer mediated inner membrane organization 
(Rabl et al., 2009). The affect of Mio10 on oligomerization of the F1FOATPase was 
assessed using the in-gel activity assay. In contrast to previous in-gel activity assays, 
digitonin concentrations were reduced to 0.35% and a 3-13% BN-PAGE gel gradient 
was used to better solubilize and separate larger complexes. The absence of Mio10 
however does not negatively or positively affect F1FOATPase oligomerization. 
Whether MIO10 overexpression has a similar effect on F1FOATPase oligomers, as 
Fcj1, is yet to be determined.  
 
5.1.5 F1FOATPase dimerization in higher eukaryotes   
Analysis of the MIO10 deletion mutants indicated that Mio10 does not affect 
F1FOATPase activity or its organization into dimers or higher oligomers. In 
conjunction with BN-PAGE analysis and biochemical isolations of tagged 
F1FOATPase subunits, it is concluded that Mio10 and MINOS1 are not F1FOATPase 
dimerization factors. This raises the question of what mediates F1FOATPase 
dimerization in higher eukaryotes. It may be possible that different factors mediate 
dimerization across the species divide. The human IF1 protein promotes F1FOATPase 
dimerization whereas its yeast homolog, Inh1, does not have a role (García et al., 
2006). The observation that homologs of Atp18 and Atp19 are not found whereas 
homologs of Atp20 and Atp21 have no proven role in F1FOATPase in higher 
eukaryotes may indeed suggest that small dimerization factors are not required in 
higher eukaryotes. Nonetheless, the in silico approach used in this study was not 
successful in identifying novel dimerization factors and perhaps different approaches 
are needed. One possibility would be affinity purification based mass spectrometric 
analysis of tagged F1FOATPase subunits. This may help identify novel components 
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that may associate with the F1FOATPase in higher eukaryotes. The question of what 
mediates F1FOATPase dimerization in higher eukaryotes remains outstanding. 
 
5.2 The MINOS complex: Mitochondrial inner membrane organizing 
system complex   
 
5.2.1 Identification of the yeast MINOS complex  
As initial analysis indicated that neither Mio10 nor its human homolog MINOS1 are 
F1FOATPase dimerization factors, the question of Mio10/MINOS1 function still 
remained. Biochemical isolations from a Mio10SF tagged strain were performed 
followed by mass spectrometric analysis to identify Mio10 interaction partners. 
Whereas, results further verified the lack of interaction with the F1FOATPase, they 
indicated a possible Fcj1 interaction. This was also shown when Mio10 was 
successfully coisolated with Fcj1 from a Fcj1zz strain. Fcj1 and its human homolog 
Mitofilin, play a major role in the organization of the inner membrane as mutants that 
lack Fcj1 or Mitofilin exhibit aberrant cristae morphologies (John et al., 2005; Rabl et 
al., 2009). This Mio10-Fcj1 interaction suggested that Mio10 could also be involved in 
inner membrane organization.  In addition, many of the proteins that are found in the 
mass spectrometric analysis either uncharacterized and/or AIM proteins (Aim5, 
Aim13, Aim37, Aim38, Aim45).  These proteins were found in screens that affect 
mitochondrial inheritance and may suggest other possible roles of Mio10 (Hess et al., 
2009). However, due to the lack of antibodies against these proteins, it was difficult to 
verify some of the interactions. It should be noted that mass spectrometric analysis of 
Mio10SF immunoprecipitation was not quantitative. The analysis was mainly based on 
spectral counts and normalized fold changes between elutions from tagged against 
wildtype untagged strains. Thus, it would be of interest to repeat the isolations with 
SILAC-based mass spectrometry, which might provide a more quantitative analysis 
that would further verify results of this study (Ong et al., 2002). Nonetheless, data 
indicated a Mio10 interaction with Fcj1, and therefore a possible similar role in cristae 
biogenesis. 
 
A function for Mio10 in mitochondrial inner membrane organization was 
investigated using the mio10∆ strain. Whereas mio10∆ cells were not affected at 30°C, 
cells lacking Mio10 showed a growth defect at 18°C and to lesser extent at 37°C when 
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grown on minimal non-fermentable medium. A growth defect at elevated temperatures 
may indicate a change in membrane biogenesis and stability as shown in various 
mutants involved in cardiolipin biosynthesis (Joshi et al., 2009). Interestingly, fcj1∆ 
cells had a similar growth behavior to mio10∆ cells.  Upon further investigation of 
mitochondria isolated from mio10∆ grown at 18°C, no strong changes were observed 
at mitochondrial protein steady state levels. Live fluorescence microscopy was used to 
evaluate mitochondrial network organization of mio10∆ cells, which appeared to be 
more condensed compared to the wildtype strain. In fact, mio10∆ and fcj1∆ cells 
displayed very similar condensed mitochondrial networks, supporting the notion of a 
common Mio10/Fcj1 function. In contrast, atp20∆ mitochondria were fragmented, 
highlighting their different functional role in mitochondrial membrane organization. 
Mitochondrial dynamics (fusion/fission) provides a mechanism for compromised 
mitochondria to complement their damaged components with contents from healthy 
mitochondria (Ziviani and Whitworth, 2010). Indeed, the aberrant mitochondrial 
network dynamics observed in the examined mutant strains may be due to higher 
mitochondrial turnover. Mitochondria are degraded by mitophagy, which is the 
selective autophagy of mitochondria (Kanki et al., 2008). Previous studies have used 
an experimental system in which the mitochondrial outer membrane protein, Om45, is 
tagged with GFP and then used to monitor mitophagy (Kanki et al., 2009). A similar 
system thus can be applied to investigate mitophagy in mio10∆ and fcj1∆ cells. 
 
On the other hand, analysis by electron microscopy revealed a strong aberration 
in the organization of the inner membrane when Mio10 was absent. The MIO10 and 
FCJ1 deletion mutants exhibited leaflet-like stacked cristae membranes compared to 
the wildtype. Also, both mutant strains appear to have lost defined cristae tips. The 
observed phenotype is in agreement to previous reports of fcj1∆ mutants (Rabl et al., 
2009). It is also clearly distinct from the onion-like organization observed in atp20∆ 
mitochondria and thus ruling out a common function (Paumard et al., 2002b).  
Previous work on fcj1∆ using tomography indicated that the observed stacked 
membranes have lost cristae junctions and are stacked by F1FOATPase dimer 
interactions between one membrane and another (Rabl et al., 2009). This may hold 
true for mio10∆ mitochondria, which have a remarkably similar inner membrane 
organization. All in all, the sum of data (biochemical isolations and MIO10 deletion 
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mutants analysis) indicates that Mio10 is a novel interaction partner of Fcj1 that is also 
involved in mitochondrial inner membrane organization. 
 
5.2.2 Identification of the human MINOS complex  
In order to identify possible interaction partners of MINOS1 in human mitochondria, 
coimmunoprecipitation using MINOS1 specific antibodies were performed and 
isolated complexes were further analyzed. For this purpose, SILAC-based quantitative 
mass spectrometry analysis was performed, as well as a label-switch experiment. To 
this end, analysis of MINOS1 containing complexes from human isolated 
mitochondria indicated a significant enrichment of Mitofilin. Also, in agreement with 
previous studies, various Mitofilin interactors such as Metaxin 1, Metaxin 2, 
CHCHD3, HSPA9, DnaJC11, and SAM50 were also significantly enriched (Xie et al., 
2007; Darshi et al., 2011; An et al., 2012). This finding highlights the efficiency of the 
experimental approach. The evidence of MINOS1 interaction with Mitofilin and 
CHCHD3 links MINOS1 with a role in cristae morphology. Results also verify the 
model that Mitofilin, which is located at cristae junctions effectively bridges the inner 
the outer mitochondrial membranes (Xie et al., 2007; Darshi et al., 2011). The 
MINOS1 interactions with Mitofilin, CHCHD3, and HSPA9 were verified by Western 
blot analysis. However, other interacting proteins could not be verified due to the 
unavailability of antibodies. Nonetheless, the results from the SILAC-based approach 
indicate that Mio10-Fcj1 interaction is conserved in higher eukaryotes. 
 
In contrast to the enrichment of mitochondrial proteins, various non-
mitochondrial proteins were also enriched. Enrichment of GDI1 (GDP Dissociation 
Inhibitor), which is involved in Rab GTPase cycle, may provide a link to vesicle 
transport and perhaps signaling between mitochondria and the extra-mitochondrial 
space (Bachner et al., 1995). Conversely, MIA3/TANGO1 is an endoplasmic 
reticulum (ER) integral membrane protein (Saito et al., 2009) and may implicate ER 
mitochondrial interactions. Indeed, an ER-mitochondria encounter structure (ERMES), 
which forms a junction between the two organelles, has been previously identified in 
yeast (Kornmann et al., 2009; Stroud et al., 2011). ERMES contains an ER-anchored 
Mmm1, and the mitochondrial proteins Gem1, Mdm10, Mdm12, and Mdm34 
(Kornmann et al., 2009; Stroud et al., 2011). Coincidently, these ERMES components 
are also in involved mitochondrial maintenance and morphology (Okomoto and Shaw, 
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2005). The observation that ERMES components interact with the SAM complex 
further indicates a possible involvement of MINOS with ERMES (Meisinger, et al., 
2004, 2007). A role of ERMES in connecting mitochondria to the cytoskeleton has 
been also proposed (Buldogh et al., 2003). This can be exemplified by Miro, the 
homolog of Gem1 in higher eukaryotes, which can act as an adaptor between the two 
organelles (Glater et al., 2006; Koshiba et al., 2011). This interaction between 
mitochondria and components of the cytoskeleton plays an essential role in proper 
mitochondria movement and trafficking (Okamoto and Shaw, 2005).  Interestingly, 
FAM82B (regulator of microtubule dynamics protein 1) and TUBG1 (Tubulin), which 
are also components of the microtubule cytoskeleton, are enriched in the SILAC based 
mass spectrometric analysis (Zheng et al., 1991; Oishi et al., 2007). Their interaction 
with MINOS1/Mitofilin may thus provide a link between inner membrane organization 
with mitochondrial-cytoskeleton interaction. Taken together, a MIA3 and SAM 
interaction with the mitochondrial inner membrane MINOS complex may thus provide 
a novel link between the mitochondrial inner compartment and the ER. Of course, 
more evidence with respect to these interactions is still required to be verified before 
any further speculations can be made.  
 
5.2.3 Mio10 and MINOS1 form a large complex (the MINOS complex)  
Mio10 and MINOS1 containing complexes were analyzed by size exclusion 
chromatography. Both Mio10 and MINOS1 were found to form large complexes in the 
MDa range. These complexes have a similar size to complexes that contain Fcj1 and 
Mitofilin. This is in agreement with previous reports that described Mitofilin to form a 
large mitochondrial complex (John et al., 2005). Taken together, in conjunction with 
topological and mass spectrometric analyses in yeast and human cells, results indicate 
that Mio10/MINOS1 form a large complex at the mitochondrial inner membrane. In 
human mitochondria, this complex may contain the known Mitofilin interactor 
CHCHD3 and bridges the mitochondrial membranes by interacting with the SAM 
complex. The exact composition of MINOS complex however cannot be determined 
from the results of this study. Moreover, this complex plays a role in cristae and inner 
membrane morphology, as shown by the MIO10 deletion mutants in yeast. The 
absence of this complex leads to aberrant inner membrane organization. Hence, this 
complex was termed MINOS: Mitochondrial Inner membrane Organizing System 
(Figure 35). Evidence of MINOS components in various species from yeast, 
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C.elegans, and human mitochondria, as well as high sequence conservation of 
Mio10/MINOS1, Fcj1/Mitofilin, and CHCHD3 may reflect the functional and 






Figure 35. MINOS complex is critical for cristae biogenesis. In wildtype mitochondria, the 
MINOS complex sits at cristae junctions and contributes to proper cristae membrane 
morphology and cristae tip formation. In a MINOS mutant mitochondria (mio10∆ or fcj1∆), 
the absence of the MINOS complex leads to aberrant cristae morphology exhibited by 
membrane stacks. Schematic representations of the phenotypes of wildtype and MINOS 
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5.2.4 The identification of additional MINOS components  
During the revision process for the Alkhaja et al., 2012, three publications also 
reported the identification of the yeast MINOS complex (Hoppins et al., 2011; Harner 
et al., 2011; von der Malsburg et al., 2011). In all three studies, Mio10 (ORF, 
YCL057c-A) has been identified to play a role in cristae junction formation and inner 
membrane organization and morphology. This role is mediated by its interaction with 
Fcj1. Moreover, four other components of the MINOS complex have been also 
identified: YGR235C, Aim5, Aim13, and Aim37. Interestingly these proteins have 
been identified in the mass spectrometric analysis of Mio10SF biochemical isolations, 
performed in this study. Von der Malsburg et al. identified the component the MINOS 
in an affinity purification screen using a Fcj1zz strain coupled with SILAC-based 
quantitative mass spectrometric analysis, whereas Harner et al. identified the 
components by analyzing the proteome of contact sites. These sites are regions at 
which the outer membrane and inner membrane appear to meet (Hackenbrock, 1968). 
In contrast, Hoppins et al. identified the MINOS complex using a quantitative genetic 
interaction map. The systematic map was based on pair-wise measurements of growth 
defects in double mutant cells, and focused on genes encoding mitochondrial proteins 
and genes that may affect mitochondrial function. The components were found in a 
highly correlated cluster containing Fcj1 and also to a cluster containing ERMES. Like 
Mio10, these identified components affect inner membrane organization and cristae 
morphology, however with varying degrees. Table 8 represents the components of 
MINOS based on the different studies in comparison to available data with respect to 
higher eukaryotes. The following section reviews the findings of the three independent 
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Table 8. The MINOS components as identified by various studies. MINOS, von 
der Malsburg et al., 2011; MICOS, Harner et al., 2011; MitOS, Hoppins et al., 2011. 





MINOS MICOS  MitOS MINOS 
Mio10 Msc10 Mos1 MINOS1 
Fcj1 Fcj1 Fcj1 Mitofilin / IMMT 
Aim5 Msc12 Aim5 n/a 
Aim13 Msc19 Aim13 n/a 
Aim37 Msc27 Aim37 
Mio27  Msc29 Mos2 
MOMA-1 
n/a n/a n/a CHCHD3 
 
Topological analysis indicated that all identified components, besides Aim13, 
were integral inner membrane proteins with domains exposed to the IMS. Aim13 was 
shown to an IMS protein that associated peripherally to the inner membrane. Electron 
microscopy analysis of the different mutants indicated that mio10∆ and fcj1∆ had 
similar phenotypes in which mitochondria exhibited stacks of lamellar cristae. The 
observed phenotypes are in agreement with electron microscopy analysis performed in 
this doctoral study.  Also, whereas mio27∆ mitochondrial had no considerable defects, 
aim5∆, aim13∆, aim37∆ exhibited intermediate phenotypes. Results indicate that Fcj1 
and Mio10 are the main functional components of the MINOS complex. The 
conclusion that cristae membranes loose their association with the IBM is fcj1∆ and 
mio10∆ is also made (von der Malsburg et al., 2011).   
 
In agreement with results presented in this study, the MINOS complex was also 
shown to interact with the TOM and SAM complexes of the mitochondrial outer 
membrane (von der Malsburg et al., 2011, Harner et al., 2011). A MINOS interaction 
with Mia40 was also observed (von der Malsburg et al., 2011). The Mia pathway with 
its components Mia40 and Erv1 mediate oxidative protein folding by disulfide bond 
formation, which drive translocation and proper targeting of a certain mitochondrial 
IMS proteins (Herrmann and Riemer, 2012). However, an interaction with Mia40 was 
argued to be specific to Fcj1 and not other MINOS components. Fcj1 thus may have 
distinct functions in either inner membrane organization or protein import. Moreover, 
it is shown that Fcj1 copurifies with Ugo1, which is required for mitochondrial fusion 
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in concert with its interaction partner Fzo1 (Sesaki and Jensen, 2004; Hoppins et al., 
2011). The data thus not only links the MINOS complex with mitochondrial protein 
import  (TOM, SAM) but also to the mitochondrial network dynamics. This also 
parallels results of this doctoral study which indicated potential interactions with the 
SAM complex and also ERMES components. All in all, the results of the recent 
studies are in agreement with the findings of this doctoral study and support the model 
of the MINOS complex involvement in inner membrane organization.  
 
5.3 Conclusions and Outlook  
The mitochondrial inner membrane is morphologically dynamic. Various inner 
membrane proteins are known to contribute to the shape and structure of cristae 
membranes. F1FOATPase dimers contribute to a strong local curvature and thus the 
angular shape of the cristae apex (Strauss et al., 2008; Seelert and Dencher, 2011).  
Mutants that lack the Atp20 or Atp21 dimerization factors exemplify the importance of 
F1FOATPase dimerization with respect to cristae morphology. These mutants clearly 
exhibit mutant inner mitochondrial organization that characterized by concentric 
‘onion-like’ structures (Paumard et al., 2002b; Arselin et al., 2003; Arselin et al., 
2004). Moreover, Mitofilins (Fcj1 in yeast) has been previously shown to be an 
important determinant of cristae junction formation by acting in an antagonistic 
manner in inner membrane curvature with respect to F1FOATPase dimers (Rabl et al., 
2009). Whereas this study did not result the identification of novel F1FOATPase 
dimerization factors, Mio10/MINOS1 are identified as novel interaction partners of 
Fcj1/Mitofilin. This study also provided evidence for the MINOS complex playing a 
critical role in inner membrane architecture. The role of Mio10 in cristae morphology 
in yeast was shown by the analysis of MIO10 deletion mutants in comparison to other 
strains. The results of this study is paralleled and verified by three other studies, which 
have in addition identified four other components of the MINOS complex (Hoppins et 
al., 2011; Harner et al., 2011; von der Malsburg et al., 2011). Comparison of the 
phenotypes of the various MINOS mutants, indicated that the deletion of MIO10 and 
FCJ1 lead to more severe cristae aberrations. The absence of either protein also leads 
to complete dissociation of the MINOS complex in yeast (von der Malsburg et al., 
2011). It thus appears that Mio10 is one the main components of the yeast MINOS 
complex.  
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Results from this study and other publications support the notion that MINOS 
is a multifunctional complex (Figure 36). Beside the obvious role in cristae 
morphology, the MINOS may play a role in mitochondrial protein import by its 
interaction with SAM, TOM, and MIA components (Xie et al., 2007; von der 
Malsburg et al., 2011; Harner et al., 2011). By its interaction with Ugo1, the MINOS 
complex plays a role in fusion and mitochondrial network dynamics (Harner et al., 
2011). Moreover, it may have a role in mitochondrial inheritance via its components, 
Aim5, Aim13, and Aim37 (Hess et al., 2009). MINOS interaction with cytoskeleton 
proteins (FAM82B and Tubulin) may indicate its role in mitochondrial trafficking. 
Furthermore it may play a role in ERMES and ER mitochondrial dynamics via its 
interaction with ER resident proteins (TANGO1). This notion is further supported by a 
strong genetic interaction of MINOS and ERMES genes (Hoppins et al., 2011). 
Besides its link to apoptosis via Mitofilin interaction with OPA1 (Darshi et al., 2011), 
the MINOS complex may also play role in cancer. Indeed, MINOS1 proteins levels are 
elevated in prostate cancer cells (Lin et al., 2005). In addition, overexpression of 
CHCHD6 in human cancer cells enhances resistance to genotoxic anticancer drugs, 
whereas its knockdown increases its chemosensitivity (An et al., 2012). Other than its 
proven role in inner membrane architecture, any role MINOS might have in other 
mitochondrial and non mitochondrial processes remains speculative and further 
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Figure 36. MINOS is a multifunctional protein. Besides the MINOS role in cristae 
morphology, results from various sources indicate potential MINOS interactions with ERMES 
(via SAM and TANGO1), mitochondrial trafficking (Tubulin), mitochondrial import (TOM, 
SAM, Mia40), mitochondrial fusion/fission (Ugo1), and mitochondrial inheritance (AIM 
proteins of the MINOS complex).  
  
Besides the characterization of novel roles MINOS may have in mitochondria 
and other cellular organelles, information is still required with respect to the structure 
and exact function of MINOS in inner membrane organization. For instance, the exact 
composition of the MINOS complex in higher eukaryotes remains an open question. 
Still, it may be postulated from available data that MINOS in higher eukaryotes 
contains at least MINOS1, Mitofilin, CHCHD3 and CHCHD6. It should also be 
considered that the composition of the MINOS complex might vary across the species 
divide. A homolog of Aim5 and Aim13 is not found in higher eukaryotes whereas a 
homolog for CHCHD3 is not found in yeast (Herrmann, 2011). The MINOS complex 
may require at least Mio10/MINOS1 and Fcj1/Mitofilin, whereas other components 
may vary. One possible approach would be performing an affinity purification based 
mass spectrometric analysis of a tagged MINOS1 or Mitofilin in human cultured cells. 
This would be comparable to the approach in which all MINOS components were 
identified in yeast (von der Malsburg et al., 2011). In addition, the effect of the roles of 
Mitofilin, CHCHD3, and CHCHD6 are well documented as their depletion leads to 
aberrant mitochondrial cristae (John et al., 2005; Darshi et al., 2011; An et al., 2012).  
To this end, it would be valuable to investigate the effect of MINOS1 knockdown by 
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RNAi in human mitochondria and whether the role of MINOS1 in the MINOS 
complex is as essential as the yeast Mio10.  
 
More evidence is still required to understand how the MINOS complex and its 
components exert their function in cristae biogenesis. It should be noted that most of 
the of evidence related to the roles of these inner membrane proteins have been 
deduced from tomographies of mutants, whether yeast or human cultured cells. These 
tomographies represent single-point illustrations of the mutations effects but provide 
limited insight onto the dynamics governing how cristae membranes are rendered 
‘online-like’, ‘stacked’, or ‘vesicle-like’. This further highlights the extent to which 
cristae propagation, maintenance, and dynamics remain to be studied.  
 
Analysis of the MINOS mutants indicted that that MINOS complex affects 
cristae junction opening diameters (Rabl et al., 2009; von der Malsburg et al., 2011; 
Hoppins et al., 2011). It also plays a role in maintenance of cristae tips, exemplified by 
the lack of cristae tips in various MINOS mutants. In the absence of MINOS 
components, the cristae membranes appear detached from the IBM and form stacks 
that are linked together with the F1FOATPase (Rabl et al., 2009; von der Malsburg et 
al., 2011). MINOS might thus have a role in cristae biogenesis: cristae tip formation, 
cristae membrane curvature, junction maintenance; and cristae membrane propagation 
(Figure 37).  





Figure 37. Overview of MINOS roles in cristae biogenesis. A) By inducing positive 
membrane curvature, MINOS leads to invagination of the inner membrane and eventual cristae 
tip formation. In the absence of MINOS, cristae tips are not found. B) The large molecular size 
of MINOS might regulate cristae junction width. In the absence of some MINOS components, 
cristae membranes appear to have narrower cristae junctions. C) MINOS might have a role in 
the regulation cristae fusion. In the absence of MINOS, fission of cristae membrane is active 
whereas fusion discontinues. This may lead to an increase in cristae vesicle, which are then 
stacked by F1FOATPase dimers.  
 
MINOS may affect cristae junction due its large molecular size and by its 
interaction with OPA-1. OPA-1 controls cristae opening size by forming a scaffold at 
the opening that prevents premature release of cytochrome c under non-apoptotic 
conditions (Frezza et al., 2006).  The role of MINOS in cristae biogenesis may be 
explained by the invagination cristae model, which postulates that cristae tips and 
membranes can result from 1) continuous inner membrane biogenesis and but constant 
outer membrane growth and 2) large complexes that enforce membrane curvature 
(Renken et al., 2002). The cristae membrane curvatures are mediated by the large 
MINOS complex (that forms a positive membrane curvature) and the F1FOATPase 
dimers (which form a negative curvature). Thus, in the absence of MINOS, positive 
membrane curvature is absent and no cristae tips are formed. However, this may be not 
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enough to explain the observed stacked cristae inner membranes of MINOS mutants. 
In this case, a cristae fusion/fission model may be applied.  This model proposes that 
cristae formation is dynamic, in which cristae membrane vesicles may continuously 
fuse from one site of the inner membrane and fuse to another (Zick et al., 2009). The 
notion that cristae propagation is dynamic is supported by the observation of certain 
reversible cristae morphologies (Mannella et al., 2001). Stacked membranes in 
MINOS mutants may thus be due to continuous cristae fission but a lack of fusion. The 
MINOS complex may play a role in the equilibrium between cristae fusion and fission. 
Information is still lacking to explain a variation of phenotypes within any single 
MINOS mutants (wildtype, onion-like, or intermediate). Thus, it may seem that other 
factors may be involved with respect to MINOS and cristae morphology. Further 
analysis such as the analysis of multiple deletions or knockouts of MINOS 
components may shine light on the exact role of MINOS. Moreover, high-resolution 
immunoelectron microscopy analysis of mitochondrial inner membrane in the presence 
or absence of MINOS components may provide novel insight into the mechanism of 
the complex.   
 
MINOS is not only an inner membrane organizer that forms a scaffold 
connecting the inner and outer mitochondrial membranes, but may feature in various 
other mitochondrial and extra-mitochondrial functions. Many of these functions are yet 
to be examined and further studies are required. Various outstanding questions remain 
with respect to the exact role of the MINOS complex. Nonetheless, the discovery of 
new MINOS components here may provide new insight and direction for future 
studies.  
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